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CHAPI'ER I 
INTRODUCTION 
vJorld War I caused a great increase in the demand for acetone 
which was needed in the manufacture of cordite and airplane wing dope. 
The available supplies of acetone were inadequate and researchers began 
to investigate fermentation processes for the conversion of carbohydrate 
to acetone. Northrup et. al., (1919) found, that during the fermentation 
of potatoes, high levels of acetone and ethyl alcohol were produced. 
From the fermenting potatoes, the workers isolated a microorganism 
responsible for the production of acetone and ethyl alcohol. Microscopic 
morphology showed the organism to be gram negative and rod-shaped. 
Northrup et. al., (1919) named the microorganism Bacillus acetoethylicum 
on the basis of the cell morphology and end products produced during 
the fermentation of potatoes. Reilly et. al., (1920) isolated a micro-
organism from the fermentation of corn mash. The workers found that 
during the fermentation of corn mash, there are high levels of acetone, 
butyl alcohol and ethyl alcohol produced. As the pH of the culture medium 
began to drop, there were further increases in the production of acetone. 
If the acidification of the culture medium was prevented, the production 
of acetone was curtailed. On the other hand, the addition of acetic 
acid to the culture medium resulted in increased production of acetone by 
the microorganism. Johnson et. al., (1933) studied the intermediate 
compounds in the acetone-butyl alcohol fermentation of corn mash. These 
workers discovered that the acetone produced in the culture medium and 
2 
from centrifuged washed cells of Clostridium acetobutylicum arose from 
the decarboxylation of acetoacetic acid. The production of acetic acid 
in the culture medium was found to be responsible for the decreasing pH. 
Wood et. al. (1945) studied the effect of adding (1-13c-) acetate to the 
culture medium, and found that the labeled carbon was incorporated 
exclusively into acetone. To account for this, a mechanism Has proposed 
in which two moles of acetate condense to form one mole of acetoacetate: 
the acetoacetate, in turn, is decarboxylated to form one mole each of 
acetone and carbon dioxide. 
Early work on cell free extracts of Clostridium acetobutylicum 
was carried out by Davies ( 1943). I)artial purification of acetoacetate 
decarboxylase (E. C. 4.1.1.4 acetoacetate carboxylase) was attai~ed by 
extraction of acetone powder of washed cells of Clostridiu~ 
acetobutylicum. The enzyme has an optimum pH of 5.0 and a K of 8mM. 
m 
'lhe enzyme is heat stable and is inhibited by heavy metal jons such as 
mercuric, silver, cupric and ferric. Davies also demonstrated t~~t the 
enzyme associated with Clostridium acetobutylicum is very specific for 
acetoacetate and it will not decarboxylate either alpha or other beta 
keto acids. Since its initial partial purification by Davies (191~3), the 
enzyme has been extensively purified (Hamilton and Westheimer 1959a) and 
subsequently crystallized (Zerner et. al., 1966). These procedures were 
described as follows: 
The spores of ~ridium acetobutylicum are harvested 
from sterile sand and grown in test tubes containing a 
growth medium of L (+) arabinose, trypticase, yeast 
extract, 1-asparagine, and ascorbic acid. The salt 
composition of the medium comprises magnesium sulfate 
heptahydrate, manganous sulfate monohydrate, ferrous 
sulfate heptahydrate and sodium chloride. Growth is 
evident by gas evolution after approximately 24 hours. 
After 4-7 days, the bacteria are used to inoculate 20 
liter carboys of the growth medium. After 3 days, the 
cells are harvested by centrifugation and used to pre-
pare an acetone powder. The packed cells are homogen-
ized with cold acetone in a chilled Waring blender. 
The dehydrated cells are collected on a Buchner funnel 
and washed with cold acetone. The filter cake is dried 
in vacuo and ground with a mortar and pestle. Each 
100 g of acetone powder is extracted for 2 hours at 
37'C on a rotary shaker with 1500 ml of 50 mM phosphate 
buffer, pH 5.9. The most important step in the 
purification proeedure is the precipitation of the 
active material from the clear extract by acidification 
to pH 3.8-3.9 with 2 M acetic acid. The protein is 
collected by centrifugation for 2 hours at 3900 rpm at 
4'C, The assay of this material reveals a 20-67 fold 
increase in the specific activity of the enzyme. The 
protein is collected, resuspended in 100 ml of 50 ~ 
phosphate buffer, pH 5.9 and mixed to redissolve the 
material, The suspension is clarified by centrifu-
gation at 10,000 rpm. The enzyme is precipitated out 
of the clarified solution at 60% saturation with 
solid ammonium sulfate at room temperature. The 
enzyme is collected by centrifugation, dissolved in 
10-15 ml of 50 ~ phosphate buffer and desalted by 
dialysis against phosphate buffer, pH 5.9. The 
solution is heat-activated at 55'C for 1 hour and 
purified by passing the protein through a DEAE 
cellulose column equilibrated with the phosphate 
buffer. The buffer is passed through the column 
until no more material which absorbs at 280 nm is 
observed. The column is then subjected to an ammonium 
sulfate salt gradient from 0-0.1 M. The enzyme is 
eluted in a well defined, sharp peak. Fractions which 
exhibit a 280 nmc 260 nm ratio of 1.9 or greater are 
pooled and brought to 75% saturation with ammonium 
sulfate. The precipitated· protein is collected by 
centrifugation at 10,000 rpm. Once again the material 
is dissolved in 5-10 ml of 50 ~ phosphate buffer, pH 5.9 
and crystallized at room temperature by the successive 
addition of small amounts of solid ammonium sulfate 
on a stirring rod. The growth of thin hexagonal plates 
are observed after about 12 hours. 
An interesting property of the bacterial enzyme is that of latent 
enzymatic activity. Latent activity is exposed after the enzyme is 
heated at 55'C for 1 hour. The activation by heat causes a two-fold 
3 
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increase in the enzymatic activity. The activation is first order and 
effectively irreversible (Neece and Fridovich, 1967). They reported 
that the rate of activation is not affected by dilution of the enzyme 
solution, dialysis or extensive purification. The latent decarboxylase 
will co-sediment with the expressed activity in a sucrose density gra-
dient. tTeece and Fridovich (1967) postulated that the latent material 
is converted to active enzyme by a conformational change within the 
latent enzyme. Once the latent enzyme sites are activated, they cannot 
be distinguished from the original active enzyme with respect to inhibi-
tion by monovalent anions, to substrates and to known competitive inhi-
bitors of the active enzyme. Attempts to activate latent siteG by the 
use of denaturants such as urea and ethanol, or with the additio~ of the 
proteolytic enzymes trypsin, o<-chymotryspin and pronase were unsuccess-
ful. -r-;othing is known about chemical nature of the latent sHe or 
the reason why the native enzyme contains latent enzyme sites. 
The molecular weight of the bacterial enzyme is J40,000 + 10,000 
as determined by equilibrium sedimentation (Tagaki and Hestheimer (1968a). 
After exposure to pH 2.5, 4.0 ~urea or 6.0 ~guanidine hydrochloride, 
the enzyme dissociates into its subunits. Each subunit weighs 
29,000 ~ 1,000 and it appears that the native enzyme is a dodecamer. If 
the native enzyme is subjected to a pH of 8 and 4.0 ~urea, the enzyme 
will dissociate into dimers weighing 60,000. Once the urea has been re-
moved, the dimers will reassociate to form the native dodecamer. How-
ever, if the dodecamer is dissociated into the monomers, these will not 
reassociate to form the dodecamer or any intermediate molecular species. 
5 
The amino acid content of the subunit has been determined by 
Lederer et al., (1966). Methionine is the only N-terminal amino acid 
present and lysine appears at the C-terminal. The amino acid composi-
tion shows 20 lysine residues, 12-13 arginine residues and 9 histidine 
residues. The positive charges are countered by 29 aspartic acid resi-
dues and 20 glutamic acid residues; 17 of the glutamic acid residues are 
bound as amides. At pH 5.0 it would be expected that the molecule would 
possess a strong positive charge yet its isoelectric point is 4.9 
(Lederer et al., 1966). 
The bacterial enzyme is stable at 25"C in the pH range of 4-9 
(Lederer et. al., 1966). The enzyme is inactivated by denaturants such 
as urea, guanidine hydrochloride and sodium dodecyl sulfate (Tagaki, 
1968). The enzyme is resistant to heat; heating at 70"C in a 50 ~ 
phosphate buffer, pH 5.9, results in no perceptible loss of activity 
(Autor and Fridovich, 1970b). When the enzyme is subjected to tempera-
tures above 70·c, there is an irreversible loss of activity. The loss of 
activity appears to be biphasic; there is a rapidly inactivated compo-
nent (within 10 minutes) and a slowly inactivated component (within 60 
minutes). Autor and Fridovich (1970b) postulated that during heat in-
activation, the native enzyme is converted either to an inactive enzyme 
or a modified enzyme which contains less activity than the native enzyme. 
The modified enzyme is then converted at a very slow rate to the inac-
tive species. The presence of acetylacetone will prevent the thermal 
inactivation of the enzyme up to a temperature of 85"C. It is not known 
how acetylacetone performs this action. 
Hamilton and Westheimer (1959b) first proposed that the mechanism of 
action for the bacterial enzyme occurred through a Schiff base inter-
6 
mediate formed between the beta carbonyl group of acetoacetate and a 
specific amino group in the active site. The proposed mechanism was 
based upon the observation that there occurs an obligatory oxygen ex-
change between labeled oxygen in the carbonyl position and the solvent 
water. The oxygen exchange is a necessary step in the formation of a 
Schiff base. Schiff bases are extremely susceptible to reduction by so-
dium borohydride. Fridovich and Westheimer (1962) used this information 
to demonstrate that'sodium borohydride will inhibit the bacterial en~­
matic activity. Sodium borohydride will reduce the ketimine interme-
diate which is formed between the enzyme and substrate. The reduction 
produces a complex which inactivates the enzyme by blocking the active 
site and acting as a non-competitive inhibitor. Fridovich and ~-Jestheimer 
(1962) were able to trap the Schiff base intermediate and to detect it 
radiochemically. Acetoacetate labeled in the carbonyl positjon with 
carbon-14 was reacted with the enzyme and sodium borohydride. The 
borohydride reduced an intermediate and formed a stable radioactively-
labeled enzyme complex. Unreacted acetoacetate and labeled acetone pro-
duced by nonenzymatic decarboxylation of acetoacetate were removed by 
dialysis and the radioactivity of the enzyme complex was counted by 
liquid scintillation. The borohydride reduction with labeled substrate 
resulted in an 18-fold increase in the radioactivity incorporated into 
the enzyme. The labeled enzyme Has subjected to hydrolysis with hydro-
chlorj.c acid, The hydrolysate was subjected to two dimensio:1al paper 
chromatography and radioautography. The radioautograph showed a sir.gle 
spot responsible for the radioactivity. Fridovich and 1!estheimer (1962) 
had thus trapped the Schiff base intermediate with the sodium borohydride 
reaction and given further evidence for its existen.ce. These results 
indicated that borohydride reduces a compound formed between the enzyme 
and acetoacetate and that this reduction forms a bond stable to acid 
hydrolysis. The available evidence supported the concept that the 
enzymatic decarboxylation of acetoacetate proceeds by way of a Schiff 
base intermediate. 
The amino acid sequence of the active site has been determined by 
Laursen and Westheimer (1966). The workers subjected the borohydride-
reduced radiochemically trapped enzyme to the proteolytic actions of 
trJpsin and chymotrypsin. The peptides were separated by column 
chromatography and the radioactive peptide was sequenced. The sequence 
of the peptide was identified as followsc 
- GLU - LEU - SER - ALA - TYR - PRO - LYS* - LYS - LEU 
The lysine bearing the asterisk represents the site of the Schiff 
base formation. A single one lysine residue in the active site seems 
to account for the catalytic activity of acetoacetate decarboxylase. 
Currently, the proposed scheme for the mechanism of action of aceto-
acetate decarboxylation is as follows (Warren et. al., 1966): 
7 
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CH -C-CH -COO + H20 k;-:-1 3 2 
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I+ . 
H-N -E C02+ + I -H+ H-r-E k2 ~~~-
CH -C=CH CH -C=CH CH -C-CH -C-0 3 2 
+H+ 3 ~ +2 3® 2 k3 H 
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+ N-E II -H II 
CH -C-CH CH3-c-CH3 3 3 
+H+ 
k4 ! H20 ® 
CH3-ft-CH3 +ENH2 
0 
ENH2 = enzyme 
In the first step of the mechanistic scheme, there is a nucleo-
philic attack by the episilon amino group of the reactive lysine on the 
beta carbonyl group of acetoacetate. The nucleophilic attack results in 
the formation of a Schiff base with the obligatory oxygen exchange des-
cribed by Hamilton and Westheimer (1959b). The Schiff base in the 
first reaction is referred to as the enzyme-substrate complex. The en-
zyme substrate complex is reduced to form a Schiff base salt or a 
ketimine (labeled A in the Scheme). The ketimine has a localized posi-
tive charge which pulls electrons from the carboxylate terminal by a 
process known as induction. The induced electrons stabilize the complex 
and the first product carbon dioxide is released. The resulting complex 
then undergoes reduction to form a Schiff base salt of the enzyme-pro-
9 
duct complex (labeled B in the Scheme). Both Schiff base salts 
(A and B) are susceptible to reduction by borohydride; however only the 
ketimine B salt has been isolated. Tagaki et al., (1968d) has suggested 
that the conversion of ketimine A to B is very rapid and, therefore, 
little or no reduction occurs at complex A. The ketimine B is oxidized 
to form the Schiff base of acetone and this complex subsequently under-
goes hydrolysis to yield the final product acetone and releases the free 
enzyme. 
Acetopyruvate, a 'CGmpetitive inhibitor of the bacterial enzyme, will 
protect the enzyme against reduction by borohydride (Tagaki, et. al., 
1968). Acetopyruvate is a beta diketone and thus is an analogue of the 
substrate acetoacetate. Acetopyruvate has been shown to bind to the 
active site of the enzyme; however, the acetopyruvate enzyme complex 
will not go on to form a product or any other intermediate. The 
acetopyruvate enzyme complex will not support the borohydride reduction 
because the complex formed between the analogue is electron-rich. 
Borohydride will reduce carbon to nitrogen double bonds of Schiff bases 
and Schiff base salts which are relatively electron-deficient. The 
enamine double bond formed between acetopyruvate and enzyme is electron-
rich, and therefore, not reducible by borohydride. 
Below is an example of the electron-deficient complex formed be-
tween acetoacetate and the bacterial enzyme and the electron-rich bond 
formed between acetopyruvate and the enzyme. 
CH -C-CH 
3 II 3 
+ H-N -E 
Electron-deficient Schiff base salt of acetone 
CH -C-~ 3 II 
0 
= c-eo -I 2 
~ 
Electron-rich acetopyruvate enzyme complex 
The formation of the acetopyruvate enzyme complex gives evidence 
for the existence of ketimine A in the mechanistic scheme. The aceto-
10 
pyruvate enzyme complex is an analogue of the enzyme substrate complex. 
If complex A is formed, its conversion to complex B must be very rapid 
because it has not been detected with the native substrate. 
It is possible that the oxidation and hydrolysis of ketimine B is 
the rate limiting step in the mechanism, and therefore, the concentra-
tion of B~)A. This could aocount for the fact that a borohydride 
reduced ketimine A complex has not been isolated. 
The bacterial enzyme has a K of 8 mM with an optimum activity at 
m -
pH 5.9 (Westheimer, 1963). The enzyme has a high specificity for 
acetoacetate; it has no action on alpha or other beta keto acids. The 
compounds so tested include acetopyruvate, acetone dicarboxylate, 
oxaloacetate, ~-ketoglutrate and pyruvate. Phenylacetoacetate will 
serve as a substrate, but the enzyme has a poorer K (10 ~), than the 
m 
native substrate acetoacetate (Fridovich, 1972). 
Acetoacetate decarboxylase is inhibited by structural analogues of 
the substrate, by compounds that interfere with the formation of a 
Schiff base and by numerous monovalent anions. Acetone sulfonate, an 
analogue of acetoacetate, has a KI of 10 ~· The analogue reacts with 
the enzyme to form an enzyme-substrate complex, but it will not be 
converted to an enzyme-product complex {Fridovich, 1968). The inhibitor 
11 
will support the reduction of the analogue-enzyme complex. This is very 
interesting because the borohydride reduction of labeled acetoacetate 
in the presence of acetoacetate decarboxylase occurs only in the enzyme-
product complex. This indicates two things, first, the Schiff base inter-
medtate is confirmed, and secondly, the decarboxylation step is very 
rapid. Thus, in the mechanistic scheme shown earlier, the steady state 
conditions must favor very high levels of the enzyme-product complex as 
compared to the enzyme-substrate complex (B>> A). 
Beta diketones are very potent inhibitors of acetoacetate decar-
boxylase. They will protect the enzyme against reduction by borohy-
dride in the presence of acetoacetate. The ability of beta diketones 
to inhibit the enzyme develops rather slowly. This indicates that there 
is an association of the diketone with the active site. The bindi~g 
of diketone to the active site prevents the borohydride reduction. 
Beta diketones form carbon to nitrogen bonds which are electron-rich 
and, therefore, not reducible by borohydride. 'I'he essential feature of 
inhibitor:r beta diketones is: 
0 
II 
CH -C-CH -R 3 2 
where R is some electron withdrawing group. Acetylacetone and aceta-
pyruvate, two of the simplest diketones, inhibit the enzyme by forming 
a ketimine between the epsilon amino group of lysine and the carbonyl 
group adjacent to the methyl group. Both inhibitors will prevent the 
borohvdride reduction. Removal of the inhibitors by dialysis results in 
a recovery of the enzymatic activity. Lineweaver-Burk plots demonstrate 
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that the inhibition by acetylacetone and acetopyruvate is competitive 
(Tagaki et. al., 1968; Autor and Fridovich, 1970a). 
Monovalent anions will inhibit the activity of acetoacetate 
decarboxylase. The inhibition is due to the binding of the anions to 
a cationic Schiff base salt. Four characteristics of the inhibition 
include: (a) The cationic site behaves such that the pKa is 5.8 or 
that consistent with an ammonium salt residue; (b) Binding sites indi-
cate that one anion per site is sufficient to cause a loss of activi-
ty. An increase in temperature will cause a decrease in the potency 
of inhibition by bromide; (c) There appears to be a critical ionic 
volume necessary for the inhibition by monovalent anions. As the ionic 
size increases from F- to Cl to Br-, the entropy for the reaction of 
the anion with the sensitive enzymic site becomes increasingly negative; 
further increase in ionic size going from I- to 010
3
- to Bro
3
- to ro
3
-
causes a reversal of the trend; (d) Divalent anions do not appreciably 
inhibit the enzyme (Fridovich, 1963). Table 1 lists a series of anions 
and the concentration of each anion required to cause 5o% inhjbition of 
the decarboxylation of 0.027 ~acetoacetate at pH 5.2 and at 30·c. 
Acetoacetate is produced chiefly in the liver and to some extent in 
the kidneys by a reaction in which acetyl coenzyme A reacts with 
acetoacetyl coenzyme A to form 3-hydroxy-3methyl glutaryl coenzyme A 
(Figure 1). The acetyl coenzyme A and acetoacetyl coenzyme A arise 
from the catabolism of fatty acids and ketogenic amino aclds. 
'3-Hydroxy-3 methyl-glutaryl coenzyme A is cleaved to produce acetyl 
coenzyme A and acetoacetate. Acetoacetate can undergo one of two 
Table 1 
Inhibition Of Acetoacetate Decarboxylase By Monovalent Anions.* 
Anion 
C104-
I-
N0
3
-
C103-
Tricholoroacetate 
Fridovich, I. (1963) 
Concentration for 50% Inhibition 
7 X 10-5 M 
11 X 10-5 
73 X 10-5 
100 X 10-5 
126 X 10-5 
400 X 10-5 
1,000 X 10-5 
5,000 X 10-5 
7,600 X 10-5 
10,000 X 10-5 
10,000 X 10-5 
33,000 X 10-5 
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~ormation of Acetoacetate 
0 0 
I I! CH C - CH C -8CoA + CoASH 3 2 
acetoacetylCoA 
acetyl CoA 
I 
I 0 
(CoA S L ~ -CH 
I 2 
I 
I 
OH 
I . ~o 
- C -CH C -SCoA) I 2 
CH3 
OHI 0 0 
# 
+ -0 - C -CH -2 6 l CH ~ -SCoA I : 2 
CH3 
3-hydroxy-3methylglutaryl CoA 
1 HMG-CoA Cleavage enzyme 0 ' 0 0 
1/ I # -CH3c -SCoA + CH3c - CH2 - C - 0 
acetoacetate 
Formation of J-hydroxybutyrate 
0 
CH Cf - 0 
2 
3-hydroxybutyrate dehydrogenase 
Formation of Acetone 
o o ho 
CH C~ CH ~- 0- + .· H+---~ CH C~- CH CO 3 2 3 J + 2 
Figure 1. Ketogenesis 
CoASH 
+ 
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reactions; it can be reduced to J-hydroxybutyrate or decarboxylated to 
acetone and carbon dioxide. The oxybutyrates, acetoacetate and 
J-hydroxybutyrate are transported in the blood to target tissues chiefly 
skeletal and cardiac muscle (Figure 2). In the target tissues J-hydrox-
ybutyrate is oxidized to acetoacetate. Acetoacetate is converted to 
acetoacetyl coenzyme A in the presence of succinate-acetoacetate CoA 
transferase, a pathway that appears to be minimal or absent in the liver. 
The acetoacetyl coenzyme A thus formed is cleaved by yielding 2 mole-
cules of acetyl coenzyme A which then enter the citric acid cycle. 
Many biochemistry textbooks cite the decarboxylation of aceto-
acetate to occur nonenzymatically or spontaneously (West, Todd, Mason, 
van Bruggen, 1966; Bhagvan, 1974; Karlson, 1975; Stryer, 1975; Harper, 
1977; Montgomery, Dryer, Conway, Spector, 1977). Several textbooks 
make no comments on the specifics of the reaction (Mahler and Cordes, 
1966; McGilvery, 1979; Bohinski, 1973; Cantarow and Trumper, 1975; Orten 
and Neuhaus, 1975; Conn and Stumpf, 1976). Only a few textbooks cite 
the reaction to occur enzymatically (Rafelson, Binkley, Hayashi, 1971; 
White, Handler, Smith, Hill, Lehman, 1978). 
Acetoacetic acid is a weak acid and during the overproduction of 
oxybutyrates as in the ketotic state, it will contribute to lowering the 
blood pH. The iowered blood pH causes vascular damage often associated 
with the uncontrolled diabetic. During the decarboxylation of aceto-
acetate, there is the uptake of a proton, lowering the proton pool. The 
decarboxylation of acetoacetate thus helps combat the falling blood pH. 
Van Stekelenburg and Koorevaar (1972) have presented evidence that 
human blood serum has acetoacetate decarboxylase activity. All studies 
OH 
I -Blood ·----r CH - C - CH - COO 3 I 2 
H 
D-3-hydroxybutyrate 
D-J-hydroxybutyrate (NAD+ y 
dehydrogenase tTADH+H + ~ 
Blood-----, .... 
0 
# C - CH2 - COO 
Acetoacetate 
3rvP 
oxidative phosphorylatior. 
1/2 02 
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0 
Q 
CH - CH - C 2 2 S - CoA 
Acetoacetyl CoA 
thiolase 
succinyl CoA 
-ooc - CH2 - CH2 - COO 
succinate 0 0 
U _ I/ CH3 - a CH2 - C - S - CoA 
Acetoacetyl coenzyme A 
2 acetyl 
( 
CoA- s~ 
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via citric 
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Figure 2. Ketone body utilization. 
by Van Stekelenburg and Koorevaar were conducted by measurine; the rate 
of acetone production by head space vapor gas chromatography. Blank 
or control solutions containing only acetoacetate in Tris buffer, 
pH 7.4, were always run to determine the extent of nonenzymic decar-
boxylation. Fifty-six random serum samples were collected and assayed 
for their acetoacetate decarboxylase activity. The mean activity pre-
-1 -1 
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se~:t was 62.2.! 12.9 (S.D. )!".mole min 1 of acetone formed. Interest-
ingly, all fifty-six samples demonstrated acetoacetate decarboxylase 
activity. 
Characterization of acetoacetate decarboxylase activit'r in human 
serum was first based upon a molecular weight study (Van Stekelenturg 
and Koorevaar, 1972). Serum samples were subjected to ul trafi ltra t ion 
accelerated by centrifugal force. The molecular weight cut-off of the 
membrane was 30,000. After separation, the retentate was washed with 
physiological saline and the initial volume reestablished. The filtrate 
and ret.entate were assayed for acetoacetate decarboxylase act.ivjt;. The 
filtrate did not demonstrate ar'Y acetoacetate decart.oxylase act. i. vj ty, 
while the retentate contained all the activity initially observed. Thus, 
the activity in human serum is not due to any ions, small proteins or 
peptides; the molecular weight of the active component is greater than 
30,000. 
The acetoacetate decarboxylase activities of different humar, serum 
protein fractions have been tested (Van Stekelenburg and Koorevaar, 1972). 
The albumin fraction showed by far the greatest amount of activity. The 
globulins demonstrated activity but only a fraction of that seen for 
albumin. The albumin contents of the different globulin fractions were 
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determined immunochemically by the Ouchterlony plate technique. By 
assuming the activator present in human serum is albumin-like or albumin 
itself, the activities present in the globulin fractions could be 
corrected for the albumin impurities present. By determining the amount 
of albumin and calculating the activity associated with that amount of 
albumin, these workers concluded that the globulins do not exhibit sig-
nificant acetoacetate decarboxylase activity. 
The influence of pH of the incubation medium upon the acetoacetate 
decarboxylase activity of purified human albumin was also investigated 
(Van Stekelenburg and Koorevaar, 1972). Optimal activity occurs at pH 
4.5; however, a considerable fraction of the activity is still present 
at pH 7.4. 
The influence of substrate concentration was studied by evaluating 
the K at pH 5.0 and pH 7.4. Albumin demonstrates a very poor binding 
m 
constant which is not affected by the change in pH (Van Stekelenburg 
and Koorevaar, 1972). The K was estimated to be 0.4 ~· 
m 
The effect of temperature upon the acetoacetate decarboxylase acti-
vity of albumin was also studied by Van Stekelenburg and Koorevaar (1972). 
Purified albumin diluted with physiological saline was heated at so·c 
for 15, 30 and 60 minutes respectively at pH 7.4. After 15 minutes, 
there was a 35% loss of activity, at 30 minutes a 45% loss and at 60 
minutes a 55% loss of activity. The active component of the albumin 
fraction is not heat stable. Autor and Fridovich (1970b) reported the 
thermal inactivation of bacterial acetoacetate decarboxylase to occur in 
the temperature range of 74-82·c. Heating at so·c for 30 minutes will 
cause a 5o% decrease in the activity of the bacterial enzyme. Thus, 
there is a good correlation between the heat inactivation of bacterial 
and mammalian acetoacetate decarboxylase activity. 
Human serum albumin has been subjected to various inhibitors of 
bacterial acetoacetate decarboxylase. Davies (1943) showed that the 
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bacterial acetoacetate decarboxylase would be totally inactivated in the 
presence of a 10-5 ~ concentration of HgC12• Van Stekelenburg and 
~ ~ Koorevaar (1972) observed no loss in activity with HgC12 at 10 , 10 
or 10-3 ~; however, at 1o-2 ~' the decarboxylase activity of albumin was 
inhibited by 76%. 
The influence of monoiodoacetate upon the acetoacetate decarboxy-
lase activity of purified albumin has been studied. At a concentration 
of the inhibitor of 10 ~' 74% inhibition was found (Van Stekelenburg 
and Koorevaar, 1972); at the same concentration, the bacterial enzyme 
activity is inhibited by 6)% (Davies, 1943). 
Urea will also inhibit the acetoacetate decarboxylase activity of 
the albumin fraction (Van Stekelenburg and Koorevaar, 1972). In the con-
centration range of 0-10 M, the highest inhibition attained was 45% and 
at 10 M. The active component can be denatured and inhibited to some 
extent, but very high concentrations of urea are necessary. At a con-
centration of 10 ~ urea, 45% inhibition of activity was attained. 
The effect of increasing concentrations of EDTA (ethylenediamine-
tetraacetic acid) upon the activity of purified albumin has been studied 
(Van Stekelenburg and Koorevaar, 1972). Interestingly, at low concen-
trations, 1-3 ~' there is an activation of the decarboxylase activity. 
Above 3 ~' inhibition is observed; this reaches a maximum of 30% at 
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9 ~· No explanation has been given as to why a chelating agent will 
increase the acetoacetate decarboxylase activity of the purified albumin. 
In contrast to the findings of Davies (1943), Van Stekelencurg and 
Koorevaar (1972) observed no inhibition of acetoacetate decarboxylase by 
pyruvic acid. The concentration range employed for pyruvic acid was 
similar to that used for the bacterial enzyme studies. In all previous 
inhibition studies by these workers, the concentration needed to inhibit 
the decarboxylase activity of albumin was always greater than that re-
quired to inhibit the bacterial enzyme. It is not known why Van 
Stekelenburg did not increase the concentration of pyruvic acid. 
Vitamin B2 (lactoflavin) acts as an activator for the decarboxylase 
activity observed in purified human albumin. The activation is much 
greater than that observed with EDTA. However, like EDTA, as the con-
centration increases, there is a reversal in the role of vitamin B2• At 
a lactoflavin concentration of 1 )lg/ml, the original activity is doubled. 
Above 1 yg/ml, the activity declines until at 6 )lg/ml of lactoflavin 
the reaction is inhibited by 40%. 
Koorevaar and Van Stekelenburg (1976) performed an extensive study 
of the reaction kinetics for the decarboxylation of acetoacetate in the 
presence of Fraction V human serum albumin. The relationship between 
the enzymatic activity and substrate concentration was found to be 
sigmoidal in nature. The reaction deviates from normal Michaelis-Menten 
kinetics and, therefore, the K has been estimated to be equal to or less 
m 
than 0.1 ~· The binding constant is better than reported earlier 
(Van Stekelenburg and Koorevaar, 1972); however, it is still very poor. 
Even though the minding constant is poor, albumin still demonstrates 
reaction kinetics. 
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Seeley (1955) reported that rates of decarboxylation of acetoacetate 
are increased in the presence of organ extracts. Koorevaar and Van 
Stekelenburg (1976) investigated whether this effect could be due to the 
presence of mild reducing substances in the incubation medium. Decarbo-
xylase activity was determined in the presence and in the absence of 
glutathione and cysteine. It was found that the reducing agents did in-
crease the rate of non-enzymatic decarboxylation of acetoacetate, but 
had no effect upon the activity associated with the albumin fraction 
tested. Thus, the increased decarboxylation rates observed by Seeley 
(1955) could be due to the presence of small organic SH-group containing 
substances in the organ extracts. 
Because of the well known microheterogeneity of albumin (Hughes, 
1964), Koorevaar and Van Stekelenburg investigated whether or not there 
is a localization of acetoacetate decarboxylase activity within one of 
the various albumin subfractions obtained by column chromatography. 
Human albumin (Mann Research Laboratories, cat #1702) was passed through 
a Sephadex G-200 column. Three peaks containing protein were resolved. 
The peaks were reported to represent the monomer, dimer and trimer (and 
higher polymers) of albumin. Each peak was divided into subfractions 
and assayed for decarboxylase activity. The specific activity of the 
subfractions was found to be homogeneous. It was concluded that the 
acetoacetate decarboxylase activity is bound tightly to the albumin 
molecule and that the en~matic activity does not depend upon the degree 
of polymerization of the albumin molecule. 
To obtain further evidence on the coupling of the decarboxylase 
activity to albumin, Koorevaar and Van Stekelenburg (1976) subjected 
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Fraction V human serum albumin to ion exchange chromatography with DEAE 
Sephadex A-50. Two peaks were obtained from the elution. One peak con-
sists of mercaptalbumin, while the other was considered to be a mixture 
of non-mercaptalbumin and polymers of albumin. The mercaptalbumin peak 
was found to exhibit low specific activity. It is possible that the ac-
tivity present in the mercaptalburnin peak is due to the contamination of 
non-mercaptalbumin and polymers of albumin. The non-mercaptalbumin peak 
was divided into two subfractions and shown to contain a high specific 
activity. It was concluded that the free SH-group of mercaptalbumin 
interferes in some way with the acetoacetate decarboxylase activity. 
Koorevaar and Van Stekelenburg (1976) assayed fifty-six serum samples 
obtained from patients ohosen at random and found a positive correlation 
between the acetoacetate decarboxylase activity and the corresponding 
albumin concentration of the patient. In the study of the fifty-six sera, 
43 specimens showed specific activities within the range found for puri-
-1 -1) fied human albumin (1.49! 0.18 (S.D.) )lmole min g albumin , with a 
-1 -1 
mean value of 1.48 umole min g albumin The remaining sera showed 
significant deviations from the mean. Some of the extreme values ob-
tained were: an oligophrenic patient, with hypertelorisma, 0.6JJ a 
patient with a mild compensated, metabolic acidosis 0.80; a ketotic 
diabetes mellitus patient, with decreased kidney function 0.94: a patient 
with collagenosis 1.11; a patient who died from a hemolytic uremic 
syndrome 2.1); and a ketotic diabetes mellitus patient with a nephrotic 
syndrome ).85 umole min-lg albumin -t. It is not known why differences 
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exist for the patients in the disease states mentioned above. 
Acetoacetate decarboxylase activity has also been observed in 
mammalian organ extracts (Koorevaar and Van Stekelenburg, 1976). Liver, 
kidney and brain from adult male rats were homogenized and subsequently 
fractionated. Five fractions were obtained: 1. the original homogenate; 
2. the nuclear fraction; J. the mitochonodria; 4. the lysosome fraction 
and 5. the supernatant. The specific activity (pmole min-1g protein-1) 
of the original brain homogenate was found to exceed that of kidney and 
liver. With respect to the liver, the specific enzyme activities do not 
differ much for the tissue fractions except for the nuclear fraction 
whose specific activity was very low. The kidney had approximately the 
same specific activity in all fractions with the exception of that of the 
mitochondrial fraction which was very low. Brain tissue was found to 
contain its highest specific activity in the nuclear fraction, and 
higher as well when compared to the values obtained for the tissue frac-
tions of liver and kidney. No explanation has been given for the 
different activities observed among the subfractions of the organ extracts. 
Generally, in the schemes of mammalian biochemical pathways, the 
decarboxylation of acetoacetate is said to occur nonenzymatically, From 
experiments by Koorevaar and Van Stekelenburg (1976) the nonenzymatic 
decarboxylation of acetoacetate at pH 7.4 and J7"C appears to be a first 
order reaction. In a blank or control sample, it has been calculated 
that 0.65,% of the original acetoacetate present is decarboxylated in one 
hour. In the presence of a normal serum, a decarboxylation velocity of 
1).5% of the original substrate concentration per hour was found. Based 
~ 
upon this fact, these workers believe that the nonenzymatic decarboxyla-
tion of acetoacetate is of no, or minor, biochemical significance. 
Peters (1970), in a lengthy review of serum, states that albumin 
has many functions and raises the question, are there undetected 
functions? Koorevaar and Van Stekelenburg (1976) believe that albumin 
has another function; to help defend the body against ketosis. 
25 
Statement of the Problem 
Van Stekelenburg and Koorevaar (1972) have given evidence that the 
decarboxylation of acetoacetate in mammalian syGtems may occur enzy-
matically. Human serum albumin seems to possess en~matic properties 
which are similar to those observed for the bacterial enzyme acetoace-
tate decarboxylase. The human serum albumin fraction demonstrates acti-
vity that: (1) is not ultrafiltrable, (2) has an optimum pH of 4.5, 
(J) has enzyme-like substrate dependency, (4) is inhibited by mono-
iodoacetate, urea and HgC12 , (5) exhibits heat instability at so·c and 
(6) is activated by lactoflavin. From fractionation studies of human 
serum albumin by means of gel filtration with Sephadex G-200, it has been 
concluded that the degree of polymerization has no effect upon the 
acetoacetate decarboxylase activity (Koorevaar and Van Stekelenburg, 
1976). Homogenates and the subfractions of rat brain, liver and kidney 
tissues were shown to possess acetoacetate decarboxylase activity. 
The dissertation study has investigated four aspects of the decar-
boxylation reaction. First, Van Stekelenburg reported in 1972 that rat 
liver homogenates possessed acetoacetate decarboxylase actjvity. To 
follow this aspect, a partial purification of acetoacetate decarboxy-
lase was attempted from bovine liver. Second, the inducibility of the 
enzymatic activity was determined by placing rats under the stress of 
ketosis. Rats were made diabetic with streptozotocin and their acetoace-
tate decarboxylase activity was monitored in plasma samples. Third, 
further characterization of the acetoacetate decarboxylase activity was 
performed on sgmples of Fraction V human serum albumin. Fourth, 
experiments were performed to gain insight into the mechanism of 
decarboxylation of acetoacetate by albumin. 
CHAPTER II 
MATERIALS AND METHODS 
Assay of Acetoacetate Decarboxylase. 
Acetoacetate decarboxylase activity was measured by following the 
production of acetone from the lithium salt of acetoacetate by head 
space vapor gas chromatography (Van Stekelenburg and DeBruyn, 1970). 
To control extraneous activity or breakdown of acetoacetate, recommenda-
tions suggested by Van Stekelenburg and Koorevaar (1972) were taken into 
consideration. (1) Acetoacetate is chemically unstable; therefore, it 
is necessary to measure the nonenzymatic decarboxylation of substrate in 
each experiment (blank experiments). (2) To maintain conditions of 
equilibrium between the acetone concentration in the vapor and in the 
aqueous phase, all experiments were carried out in a shaking waterbath 
thermostated at 37'C. (3) The acetone concentration in the vapor phase 
depends not only upon the concentration of acetone in the aqueous phase, 
but it also depends upon the osmolality of the aqueous phase. (4) In 
general, the acetoacetate decarboxylase assays were run for four hours 
and the concentration of acetone was determined five or six times during 
the incubation period. 
The acetoacetate decarboxylase reaction was carried out in 40 ml 
rubber-stoppered vials. The reaction mixture contained 2.7 ml of 50 ~ 
Tris buffer, pH 7.4, 0.1 ml of 0.45 ~lithium acetoacetate and 0.2 ml of 
the test material. Head space samples were withdrawn by puncturing the 
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rubber stopper with a 1 ml air-tight syringe (Pressure LuK, Series A-2 
Precision Sampling, Baton Rouge, Louisiana). The 1 ml head space 
sample was compressed to 0.1 ml and injected into the gas chromato-
graph. The syringe must be purged with extra-dry nitrogen after each 
injection to ensure that there is no build-up of residual acetone. 
The gas chromatograph used was either a Varian 2440 or a Barber-
Colman Model 5320. Both gas chromatographs were equipped with a flame 
ionization detector. The Barber-Colman gas chromatograph had an alu-
minum column, 6 ft. in length with an internal diameter of 1/4 inch. 
The injection port temperature was 220'C, the column oven temperature 
was 160'C, and the detector temperature was 220'C, The Varjan model 
had a glass column, 6 ft. in length with an internal diameter of 1/8 
inch. The injection port temperature was 250'C, the column oven temper-
ature was 170'C, and the detector temperature was 290'C. The columns of 
both gas chromatographs were packed with Porapak QS resin, 80-100 mesh 
(Anspec Company, Inc. Ann Arbor, Michigan). The carrier gas for both 
columns was zero grade nitrogen (Linde), The gas flow of nitrocer, 
hydrogen and air was 30 ml, 20 ml and JOO ml/min, respectively. 
Standard solutions of reagent grade acetone (Mallinckrodt, St. Louis, 
Missouri) were prepared containing 15, 30, 60 and 90.1"6 of acetone 
respectively in J ml of aqueous solution, The relationship between the 
concentration of acetone and the peak height in mm was found to be linear 
over the range described, 
Before an assay was performed, the validity of the standard curve 
was checked by three injections of the 90~g standard. The peak 
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heights must be monitored closely since the columns lose sensitivit:; 
with time. A new standard curve was prepared when the peak height 
determined after an incubation time of four hours for the 90 pg standard 
varied more than 5 mm from the previously determined value. 
Porapak QS is a pure white resin. After two months of use, the 
resin begins to turn brown. The brown color is readily observed through 
the glass column; and when seen, the cmlumn is repacked. The status 
of the aluminum column is checked by monitoring the retention time of 
the acetone. When the retention time increased by thirty seconds, the 
column was emptied and repacked with fresh resin. 
For the assay of experimental samples for acetoacetate decarboxy-
lase activity, the total change of the acetone concentration in the vapor 
phase expressed in mm of peak height per unit of time minus the change 
of the acetone concentration in the vapor phase of the corresponding 
blank experiment is a measure of the enzyme activity. The acetoacetate 
decarboxylase activity was expressed in terms of units. One unit of 
activity is defined as the production of lpmole of acetone per minute 
per gram of protein. An example of a typical plot for the determination 
of acetoacetate decarboxylase activity of Fraction V human serum albumin 
is presented in Figure J. In all experiments described in the disser-
tation, the source of Fraction V human serum albumin was Miles Labora-
tories, Elkhart, Indiana (Code no. 82-302, Lot no. 141). The purity of 
the albumin was stated to be 96% as determined by cellulose acetate 
electrophoresis in a 75 ~ baribital buffer, pH 8.6. 
Figure 3. Acetoacetate decarboxylase assay by head space vapor gas 
chromatography. 
The graph shows the increase in the acetone concentration (in mm 
peak height) of head space vapor during a typical acetoacetate decar-
boxylase assay. The blank reaction mixture contains 2.7 ml of 50 ~ 
Tris buffer, pH ?.4, 0.1 ml of 0.45 M lithium acetoacetate and 0.2 ml 
of deionized water. The sample reaction mixture contains 2.7 ml of 
50 mM Tris buffer, pH ?.4, 0.1 ml of 0.45 M lithium acetoacetate and 
10 mg of Fraction V human serum albumin in-0.2 ml of deionized water. 
The difference in peak height between the blank and albumin sample is 
related to the acetone concentration by use of a predetermined standard 
curve. 
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Preparation of Labeled and Unlabeled Lithium Acetoacetate. 
Lithium acetoacetate, the substrate for the acetoacetate decar-
boxylase assay was prepared according to the method of Hall (1962). The 
unlabeled substrate was prepared from ethyl acetoacetate (Fisher 
Scientific Company, Fair Lawn, New Jersey) while the labeled substrate 
was prepared from ethyl-0-14c)-acetoacetate (Amersham Corporation, 
Arlington Heights, Illinois), The labeled and unlabeled substrates are 
prepared in the same way. A mixture of 5.2 g (0.04 mole) ethyl aceto-
acetate, 25 ml water and 10.0 ml of 4.00 ~ LiOH was placed in a cork-
stoppered Erlenmeyer flask and incubated at 40'C for four hours. A pale 
yellow solution resulted, and it was evaporated to dryness under reduced 
pressure at a bath temperature of 40'C, It is essential that the flask 
contents be completely dry, otherwise the subsequent crystalization of 
the compound from a methanol-ether mixture is difficult. The crude 
lithium acetoacetate was extracted at room temperature from the dry 
crystalline mass with three successive 15 ml portions of absolute 
methanol. Insoluble material was removed by passage of the mixture 
through a Whatman no. 4 filter paper. Absolute ether was added slowly 
to the clear methanol filtrate until the solution became slightly turbid. 
The mixture was allowed to stand at room temperature for JO minutes. 
Five volumes of ether were added slowly to the mixture which was then 
chilled to 4'C, The crystals were collected by suction filtration, 
washed with ether and dried in vacuo. The product was recrystallized 
twice by redissolving the material in absolute methanol (6 ml per gram) 
removing insoluble material by filtration and adding absolute ether as 
before. The yield based on ethyl acetoacetate was 50-60%. 
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The purity of the lithium acetoacetate was determined from absorp-
tion spectra. The measurements were taken in water, in 0.1 ~ NaOH and 
in 0.1 ~ HC1. The spectra were obtained with the use of a Model DB-G 
Beckman Spectrophotometer. The concentration of the lithium acetoacetate 
in all three media was 4.00 ~; the light path was 1.00 em. The molar 
extinction coefficients at the peak absorptions of 273, 267 and 247 nm 
were respectively 47,0, 147.5 and 72.5 cm2• Hall (1962) reported molar 
extinction coefficients at the same peak absorptions of 50.0, 148.0 
2 
and 73.0 em respectively. 
The crystalline lithium salt of acetoacetate is non-hygroscopic 
and is stable for several months when kept under vacuum at 4"C. Neutral 
solutions of the lithium salt may be frozen at -10"C for 2-3 weeks 
without significant decomposition. 
Protein Determination. 
Protein was determined by utilizing the colorimetric method of 
Lowry et. al., (1951) as modified by Oyama and Eagle (1951). There are 
two distinct steps which lead to the final color development with protein: 
(1) a reaction with copper in alkali, and (2) a reduction of the phos-
phomolydic-phosphotungstic acid reagent by the copper-treated protein. 
One ml of reagent "C" was placed in each of a series of 10 X 75 mm 
polystyrene test tubes. Two hundred pl of sample was added to appropri-
ately marked tube and two hundredpl of deionized water was added to a 
blank tube. The contents of the tubes were mixed and allowed to stand 
for ten minutes. One hundred pl of Folin-Ciocalteu reagent (Hartman-
Leddon Company, Philadelphia, Pa.) was added to each tube and the tubes 
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were mixed thoroughly. The reaction mixtures were allowed to stand for 
30 minutes to allow for full color development. The absorbance of the 
sample solutions was determined with a Beckman DU spectrophotometer at 
a wavelength setting of 750 nm. The blank tube was used to zero the 
instrument. A standard curve was prepared following this procedure 
using Fraction V bovine albumin powder (Pentex Biochemicals, Kankakee, 
Illinois) as the standard. 
The concentration of the unknown sample is calculated by using the 
formula: 
Hg protein = absorbance of unknown Xconcentration X 5 absorbance of standard of standard ml of unknown sample 
~~ 
The data for the calibration curve are given in Table 2 and the standard 
curve is shown in Figure 4. 
Solutions 
1. Reagent A 
20 g of Na2co3
, 4 g of NaOH and 200 mg of KNa c4H4o6 · 4H2o 
were dissolved in one liter of deionized water. 
2. Reagent B 
5 g of Cuso4 • 5H20 was dissolved in one liter of deionized 
water. 
3. Folin-Ciocalteu Reagent 
Folin-Ciocalteu Reagent was obtained from the Hartman-Leddon 
Company and diluted with deionized water in the ratio of 5 
parts of the phenol reagent to 7 parts of deionized water as 
recommended by ~]ama and Eagle (1956), 
'Table 2 
Standard Curve Data For Protein Determination 
Albumin (pg) 
5 
10 
20 
30 
40 
50 
Number of 
Determinations 
6 
6 
6 
6 
6 
6 
* Mean .! standard deviation. 
Absorbance* 
750 nm 
0.066 + 0.002 
0.124 + 0.001 
0. 231 .! 0. 003 
0.323.! 0.003 
0.408 + 0.002 
0.497.! 0.006 
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Figure 4. Standard curv~· for protein det~rmination 
4. Reagent C 
Fifty parts of reagent A and one part of reagent B were 
mixed freshly prior to use. 
Determination of Plasma Glucose 
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During the course of this study, it was of interest to determine 
whether acetoacetate decarbo~Jlase activity was inducible during star-
vation or in the diabetic state. For the latter purpose, streptozotocin 
(Upjohn Company, Kalamazoo, Michigan) was used to induce diabetes 
mellitus in fed adult male rate~ 
The blood was collected from the tail vein while the animals were 
lightly anesthetized with sodium pentobarbital, 32.5 mg/kg of body 
weight, injected intraperitoneally. The animals were placed on their 
backs and taped into position. The tip of the tail was snipped and the 
blood was collected in Natelson heparinized micropipettes. The tail was 
milked to facilitate collection of the blood and prevent the formation 
of a clot. Three Natelson pipettes were filled before the bleeding was 
stopped. 
The plasma was obtained from the Natelson micropipettes by flaming 
shut the opposite end of the pipette used to introduce the blood. The 
closure allows the blood to be centrifuged in the pipettes without 
unnecessary transfer and possible loss of plasma. The pipettes were 
centrifuged at 2000 rpm for 15 minutes. 
were cut near the plasma/RBC junction. 
test tubes and frozen until assayed. 
After centrifugation, the pipettes 
The plasma was transferred to 
The glucose levels were monitored with a Beckman Glucose Analyzer 
(Beckman Instruments, Inc., Fullerton, California). The analyzer 
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employs an oxygen sensitive electrode and an electronic system that mea-
sures the rate of change in oxygen concentration when a sample is in-
jected into an enzyme solution. Plasma is introduced into a sample cup 
containing glucose oxidase. ~ -D-glucose in the plasma combines with 
the dissolved oxygen in the solution according to the reaction: 
~ glucose ~ -D-Glucose + o2 ~o~x-i~d~a-s~e---)+ 
The oxygen is consumed at the same rate as the glucose reacts and, there-
fore, the rate of oxygen consumption is directly proportional to the 
glucose concentration. Because oxygen consuption rather than peroxide 
formation is measured, peroxide must be destroyed by a path not leading 
back to oxygen. The destruction of peroxide can be accomplished in one 
of two ways. In the presence of catalase, ethanol reacts with hydrogen 
peroxide according to the following reaction: 
catalase ) Acetaldehyde + 2H2o 
Also, peroxide may be decomposed in the presence of iodide and molybdate 
ions according to the equation: 
molybdate } 
The enzyme reagent solution contains, in addition to the enzyme glucose, 
oxidase, ethanol, catalase, iodide and molybdate to ensure that a 
complete destruction of the generated peroxide is accomplished. 
Isoelectric Focusing 
In electrophoresis, the pH of the stationary phase is constant 
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throughout. Thus, proteins migrate according to the charge they possess 
at that pH. In isoelectric focusing, there is a pH gradient established 
by commercially available ampholytes. When current is applied to an 
isoelectric focusing column, proteins will migrate to a position in the 
pH gradient where the net charge they possess is zero. Proteins layer 
themselves in distinct bands. At the end of the electrophoretic run, the 
effluents from the column are passed through a monitoring device and 
collected with a fraction collector. 
The pH gradient, which is the basis for isoelectric focusing, is 
established by aliphatic polyamino-polycarboxylic acids. These compounds 
have small differences in pi when compared to each other. At the beginn-
ing of a run, the pH of the column is the average value for all the 
carrier ampholytes in solution. When current is applied to the column, 
the ampholytes migrate to a position where their net charge is zero. 
To prevent disruption of the pH gradient by convection, the column 
is stabilized by a sucrose density gradient. The column is prepared by 
mixing the carrier ampholytes and sample proteins in the sucrose solution. 
The sucrose solution is then layered on the column using a gradient mixer. 
After current is applied to the column, it is necessary to protect 
the carrier ampholytes located near the electrodes from anodic oxidation 
and cathodic reduction. This is done by surrounding the anode with an 
acid solution and the cathode with an alkaline solution. The carrier 
ampholytes at the anode become positively charged and these are repelled 
from the anode. At the cathode, the ampholytes become negati.vely charged 
and are repelled away from the cathode. 
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Partially purified bovine liver extracts were applied to isoelec-
tric focusing columns. The entire electrofocusing column (LKB 8100 
Ampholine Column, LKB Instruments, Inc., Rockville, Maryland) was ther-
mostated at 4"C by utilizing a cryostat (Tamson Thermostatic Path (TM-9) 
and circulator (PBC-4, Neslab Instruments, Inc., Portsmouth, New Hamp-
shire), which circulated coolant around both the inner and outer electro-
focusing columns. The coolant consisted of equal volumes of distilled 
water and ethylene glycol. The anode solution consisted of 0.2 ml of 
14.6 ~ phosphoric acid, 14 ml of distilled water and 12 grams of sucrose. 
The anode solution was introduced through a side port in the column. It 
is important to ensure that the anode is covered by approximately one 
inch of solution. The sucrose gradient was prepared by dissolving 28 
grams of sucrose in 42 mls of water and adding 3.75 ml of an LKB Ampho-
line with a pH range of J.5-10 (LKB Instruments, Inc., Rockville, rary-
land) to the solution. The solution was heated gently and stirred to 
facilitate the dissolution of the sucrose. This solution is called the 
dense sucrose solution. A light solution was prepared by dissolving 
1.25 mls of the LKB Ampholine to 60 ml of distilled water. Five ml of 
this solution was discarded (to accommodate the column volume) and 20 ml 
of the bovine liver extract was added to the light solution. The sucrose 
gradient was established through the use of an LKB Gradient Mixer, Model 
8121. After the dense and light solutions were applied to the column, 
the cathode electrode solution was added. The cathode solution was pre-
pared by dissolving 0.20 grams of sodium hydroxide in 20 ml of distilled 
water. The cathode solution was layered on the sucrose solution until the 
platinum cathode was covered by approximately 1 inch of solution. A 
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constant val tage of 500 val ts was applied to the column for a. period of 
48 hours. The power source was shut off and the bottom of the column 
opened so that the effluent could be monitored and collected. Monjtor-
ing was performed with a Uvicord Absorptionmeter and Recorder (L~J Instru-
ments, Inc., Rockville, Maryland) and fractions were collected with a 
Unifrac Fraction Collector (Savant Instrument Inc., Hicksville, New 
York). Fifty drop aliquots (3.8 ml) were collected until the column was 
completely emptied. 
The pH of the fractions was measured while cold with a Corning pH 
meter, Model 12-B, (Corning Scientific Instruments, Corning, New York) 
equipped with a Markson pH electrode (Markson Science Inc., Del Mar, 
California). 
Acylation of Human Serum Albumin 
The mechanism of action for the bacterial enzyme occurs through the 
formation of Schiff base between the carbonyl group of the acetoacetate 
and a reactive lysine residue in the active site of the enzyme, (Warren 
et. al., 1966). To investigate whether albumin has a similar mechanism, 
acylating agents such as succinic and citraconic anhydrides, were used to 
block the epsilon amino groups of lysine. 
Fraction V human serum albumin (Miles Laboratories, Inc., Elkhart, 
Indiana) was acylated with succinic or citraconic anhydride 
(2-methylmaleic anhydride). Klotz (1967) represents the acylation 
reaction to occur as follows: 
lt1 
0 
\\ 
c - CH - R 
+ I I p - (NHJ ) +X 0 
' 
n c - CH 
1/ 2 0 
- CH - R + 2 " H+ J 
I 
CH2 y 
Jonas and Weber (1970) have demonstrated from fluorescence polari-
zation measurements that the dicarboxylic anhydrides will expand the al-
bumin molecule, due to electrostatic repulsion, but that the attachments 
of acylating groups have no effect on the protein structure. Thus, 
modification of albumin by acylating agents would not be expected to 
alter the acetoacetate decarboxylase activity. 
The acylation of albumin by succinic or citraconic an.hydrjde was 
carried out as described by Jonas and ~Jeber (1970). Solid succlnvl an-
h~rdride (Eastman Kodak Company, Rochester, New York) was added slowly in 
small amounts to a 1% solution of the human serum albumin with cor:tinu-
ous stirring at room temperature. During the reaction of succinic anh:r-
dride with the epsilon amino group of lysine, there is a release of pro-
tons, The pH of the mixture is kept constant at 7 by the drop-wise 
addition of 1 M NaOH. The reaction was deemed complete when there occurred 
no further drop in the pH of the solution upon the addition of succinlc 
anhydride. The unreacted succinic anh;.:dride, which in water is largely 
hydrolyzed to succinate, was removed by exhaustive dial:sis. After 
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dial:: sis, the succinated albumin solution was lyophilized, reconstituted 
with 2.0 ml of 50 mM Tris buffer, pH 7.4 and assayed for acetoacetate 
decarboxylase activity. The succinated albumin is a stable complex and 
can be stored in the refrigerator for several days without decomposition. 
The reaction of Fraction V human serum albumin with citraconic 
anhydride (Aldrich Chemical Company, Inc., Milwaukee, Wisconsin) was also 
carried out at room temperature with continuous stirring and manual ad-
justme:!'lt of pH with 1 M NaOH to pH 8.0. The citraconyl protein is hv-
drol:rzed easily at pH values as high as 7 after several hours at room 
temperature, but when kept cold at pH 8.0 is stable for a few da:1s 
(Jonas and Weber, 1970). To speed the removal of the unreacted citra-
conic anh·1dride and restrict undesired hydrolysis, the acylated protein 
was passed through a Sephadex G-25 column (Fharmacia Fine Chemicals, 
Inc., Piscataway, New Jersey) 2.5 X 30 em, equilibrated with 50 mfvl f'ris 
buffer, pH 8.0. Volume fractions of 130 drops (approximately 10 ml per 
fraction) were collected with a Unifrac Fraction Collector (Savant 
Instruments, Inc., Hicksville, New York). The absorbance of the efflu-
ent was monitored at 280 rnrn with a Uvicord absorptionmeter and recorder 
(LKB Instruments, Inc., Rockville, Maryland). The albumin complex was 
eluted in the void volume and in a broad peak. Fractions containing the 
acylated albumin were pooled and concentrated by lyophilization. :!!:ach 
albumin-complex sample to be tested was reconstituted with 2 ml of 50 m~ 
Tris buffer, pH 8.0 and assayed for acetoacetate decarboxylase activity. 
After assay, the citraconyl albumin samples were hydrolyzed to 
remove the acylating agent. The reason for this approach was an attempt 
to recover activity lost during the acylation. If successful, this 
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procedure would lend further support for a role of the free epsilon amino 
group of lysine in acetoacetate decarboxylation. Hydrolysis was performed 
by placing the samples in 20 ml screw-capped vials with a stirring bar 
and lowering the pH to 2.5 with 0.5 ~ HCl. The samples were allowed to 
mix overnight at 4'c. After hydrolysis, the samples were agajr. passed 
through the Sephadex column to remove the 2-methylmaleic acid. Ten ml 
fractions were collected as previously described, concentrated by 
lyophilization and assayed for acetoacetate decarboxylas'; acUYHy. 
Determination of the Free Amino Group Content of Human Serum Albumin 
The extent of acylation of Fraction V human serum albumin by 
succinic and citraconic anhydrides was followed by utilizing the color-
imetrlc ninhydrin assay of Matthews et. al., (1964) for the determina-
tions of free amino groups. Ninhydrin reacts with amino acids as follows: 
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Colored l'roduct 
In this reaction, the amino acid is oxidized to an aldeh~de contain-
ing one less carbon atom. Ammonia and carbon dioxide are released. All 
true amino acids, peptides, protei~s, or any compound containing free 
amino groups undergo this reaction. In an acidic environment, one resi-
due each of reduced and oxidized ninhydrin condense with ammonia to form 
a bluish colored reaction product. The color developed differs with the 
character of the protein, the amino acid or mixtures of the two. 
' The ninhydrin method is simple to perform and it is as specific as 
the gasometric method for~-amino nitrogen (Matthews et al., 1964). The 
colored product formed during the reaction is measured spectrophotome-
trically at 570 nm. The following reagents are needed for the assay: 
Stock cyanide, 0.01 ~ NaCN. -Dissolve 490 mg in 1 liter of water. 
Cyanide -acetate buffer, pH 5.2. -To 190 g CH
3 
COONa · 3H20 add 
500 ml water and dissolve. Add 36 ml glacial acetic acid and 5 g di-
sodium EDTA. Mix well, then add 20 ml of the stock cyanide solution.and 
make up to 1 liter with water. Store at 4·c. 
Methyl cellosolve (ethylene glycol monomethyl ether) - The reagent 
should give a negative peroxide reaction with 10% KI, and a clear 
solution on mixing with water. 
Ninhydrin reagent - Ninhydrin Jfo (w/v) in methyl cellosolve. Store 
at 4'C, 
Stock standard amino acid solution -Dissolve 536 mg gl::cine in 100 
ml water (= 100 mg of NH2N per 100 ml). Preserve with chloroform and 
store at 4·c. 
Working standard - Dilute 5 ml of stock standard to 100 ml with 
water on the day of the estimation. 
Diluent - Isopropanol, mixed with an equal volume of water. 
Procedure: 
1. Into a series of 18 X 150 mm pyrex test tubes was added 0.9 ml of 
deionized water. 
2. To the appropriate tubes was added 100 pl of unknown solution or of 
deionized water. Next 0.5 ml of the cyanide-acetate buffer and 0.5 
ml of ninhydrin reagent were added. The solutions were mixed, capped 
with aluminum foil and placed in a boiling water bath for 15 minutes. 
The tubes were then removed and cooled by immersion in cold water. 
To each tube, 15 ml of diluent was added. The tube contents were 
mixed by inversion and read against water at 570 nm in 1 em cuvettes 
at a Beckman DU Spectrophotometer. 
A standard curve was prepared following this procedure, The data 
for the standard curve are given in Table 3 and the standard curve is 
shown in Figure 5. 
Borohvdride Reduction of a Postulated Schiff Base Intermediate Formed 
Between Acetoacetate and Human Serum Albumin 
The bacterial acetoacetate decarboxylase enzyme catalyzes the de-
composition of acetoacetate by forming a Schiff base wi.th the substrate. 
Schiff base intermediates formed between the bacterial enzyme and aceto-
acetate can be reduced by borohydride (Fridovich and \·iestheimer, 1962). 
The enzyme is inactivated by this treatment. To ascertain whether the 
mechanism of action of the acetoacetate decarboxylase activity associated 
with Fraction V human serum albumin involves Schiff base formation, a 
borohydride reduction was performed with a radioactively labeled substrate 
NH -N 2 
(;.tg) 
2.5 
5.0 
?.5 
10.0 
TABLE 3 
Standard Curve Data For The 
Determination Of Free Amino Groups 
Number of 
Determinations 
3 
3 
3 
3 
Absorbance* 
570 nm 
0.228 + 0.003 
0.453.! 0.003 
0.680 + 0.00() 
o. 900 .! o. 000 
* Mean ! standard deviation. 
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Figure 5, Standard curve for alpha amino nitrogen determination 
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14 ) (3- C -acetoacetate. Reduction occurs if a carbon-14 labeled altumin 
complex is obtained from the reaction mixture. Formation of a labeled 
albumin complex offers evidence for the involvement of a Schiff base 
intermediate in the mechanism of action of the enzyme. 
Ten mg samples of Fraction V human serum albumin (Miles Laboratories, 
Elkhart, Indiana) were dissolved in 2.9 ml of 50 mtl Tris buffer, pH ?.4 
and placed in 25 ml Erlenmeyer flasks. The conte~ts of the flasks were 
brought to 37'C in a shaker water bath. One hundred micro-liters of 
0.45 _!:! (3-14c) aceteacetate (5.06 X 105 dpm) (New England J!uclear, Boston, 
Massachusetts) was added to each flask. All flasks were incubated at 
37'C for 30 minutes. During the incubation period, 30 and 60 mM solu-
tions of sodium borohydride (J. T. Baker Chemical Co., Phillipsburg, 
r;ew Jersey) were prepared in 10 ml of 1 mM sodium hydroxide. Sodium 
borohydride is unstable in aqueous solution and must be kept at pH 13 
to prevent its acid-catalyzed decomposition. After the 30 minute incu-
bation period, 100 pl of the appropriate borohydride solution was added 
to the flasks to achieve a final borohydride concentration of either 1 
mM or 2mM as desired, The flasks were restoppered, the contents swirled 
and the flasks were replaced in the shaker water bath, 
Davies et al., (1962) haYe reported that borohydride is rapidly 
hydrolyzed below pH 9, Thus, at the pH of the assay mixture, the reduc-
tion of an albumin complex will occur very rapidly. The borohydride 
addition was repeated at 60, 90 and 120 minutes to ensure that a detect-
able level of the reduced albumin complex was attained, Following the 
last borohydride reduction step, the flask contents were exhaustively 
dialyzed against water to remove unreacted labeled substrate from the 
mixture. Aliquots of 500~1 of the dialysands were removed, added to 
a scintillation cocktail and the radioactivity of each sample was 
determined with a Beckman LS-250 scintillation spectrometer. 
Decarboxylation of Alpha Keto Acids 
An investigation of the effect that albumin may have on the de-
carboxylation of alpha keto acids was conducted. The assay for aceto-
acetate decarboxylase activity which measures the production of acetone 
in the head space vapor by flame ionization gas chromatograph~· is re-
producible and extremely sensitive. However, to measure the decarboxy-
lation of alpha keto acids, another method was needed since acetone would 
not be the product. Unfortunately, carbon dioxide cannot be measured 
by flame ionization gas chromatography. An alternative method was 
tried, that of thermal conductivity gas chromatography (Bollman and 
Mortimore, 1972). Carbon dioxide can be measured by this method; 
however, the sensitivity was very poor and the results were not 
reproducible. 
A method was developed in which radioactively labeled alpha keto 
acids (1-iLtC)-pyruvate and(1-14c)alpha ketoglutarate were utilized. 
During the decarboxylation, labeled carbon dioxide is released. It is 
trapped in dilute sodium hydroxide and its radioactivity counted by 
liquid scintillation. The method proved useful for studying the effect 
of albumin on the decarboxylation of alpha keto acids. 
The decarboxylation reaction was carried out in a 25 ml Erlenmeyer 
flask stoppered with a rubber septum. In the center of the septum there 
was a small hole which accommodates a long stemmed plastic collection 
bucket. The collection bucket was positioned approximately one em 
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above the reaction mixture and contained 0.3 ml of 0.1 ~ sodium h·{drox-
ide. The reaction mixture contained 10 mg of Fraction V human serum 
albumin (Miles Laboratories, Elkhart, Indiana) in 2.9 ml of 50 m~ 
Tris buffer, pH ?.4 and 0.1 ml of the (1-14c)- labeled alpha keto acid. 
The mixture of albumin and Tris buffer was brought to 37'C in a shaking 
water bath. The collection buckets containing the sodium hydroxide were 
inserted into the flasks. At appropriate time intervals, 100j<-1 of 
labeled keto acid was added to each flask; the flask was restoppered and 
replaced :tn the 37' C water bath. After two hours of ir..cubation, the 
flask was opened carefully and the collection bucket was removed. fhe 
long stem was cut from the collection bucket and the bucket was dropped 
into 10 ml of a scintillation cocktail (HC-toluene-BBS-J). ~he sdn-
ttllation vials were sealed, shaken and the radioactivitv of the sample 
was counted with a Beckman LS-250 liquid scintillation counter to deter-
mine the degree of decarboxylation. 
Measurement of Radioactivity 
A Beckman LS-250 Liquid Scintillation Spectrometer was utllized for 
all measurements of radioactivity. The samples were counted in 20 ml 
low-potassium borosilicate glass vials fitted with tin-foil-lined plastic 
screw caps. Ten ml of scintillation fluor was added to each vial. The 
fluor was prepared by dissolving 5 gm of PFO in 1 L of scintillation 
grade toluene and to every 100 milliliters of this solution was added 20 
ml of a solubilizing agent BBS-3 (Beckman Instruments, Fullerton, 
California). Liquid samples were introduced into the counting fluor 
by the use of a Gilson Pipetman automatic pipett~r (Rainen Instrument 
Co,, Brlghton, Massachusetts), The scintillation vials were capped and 
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shaken vigorously to dissolve the test material. Dark adaptation of the 
samples was complete after 30 minutes. 
The efficiency of counting was determined by the method of internal 
standardization. After all the samples were counted, 100 microliters 
of (C-14)-toluene standard (40,000 dpm, Beckman Instruments, Fullerton, 
California) was added to the vials. The samples were recounted. The 
mean value for the counting efficiency was determined to be 85.6% and 
this mean counting efficiency was used to convert counts per minute as 
recorded by the instrument to disintegrations per minute (dpm). Quench-
ing was not a problem in the measurement of the radioactivity of the 
samples. 
CHAPI'ER III 
RESULTS 
Partial Purification of Acetoacetate Decarboxylase Activity from Bovine 
Liver Homogenates 
Van Stekelenburg and Koorevaar (1972) reported that rat liver homo-
genates exhibited acetoacetate decarboxylase activity and they postu-
lated the existence of a mammalian enzyme. The initial experiments in 
this study centered on an attempted partial purification of acetoacetate 
decarboxylase activity from bovine liver. The purification of the bac-
terial acetoacetate decarboxylase from Clostridium acetobutylicum was 
reported by Hamilton and Westheimer (1959) and some of the steps of their 
procedure were used as guidelines. 
Fresh beef liver, (1700 grams) was obtained from the slaughter house 
(Lincoln Meat Company, Chicago, Illinois), packed in ice for transport 
a~d homogenized without undue delay at the laboratory in 2 liters of cold 
acetone. All steps in the preparation of an acetone powder were carried 
out in the cold room at 4'C. The homogenate was mixed for 1 hour and 
filtered with a Buchner funnel. The residue was defatted b:,· resuspend-
ing it in 2 liters of cold chloroform and mixing it for 1 hour. The mix-
ture was filtered as before. The residue was resuspended in 2 liters of 
cold acetone, stirred for 1 hour, filtered and allowed to air dry. The 
weight of dried acetone powder was 400 grams. The acetone powder was 
extracted with 2 liters of 50 m~ phosphate buffer, pH 5.9 with continuous 
stirring for 4 hours at 4'C. The solid material was then removed by 
centrifugat1.on in a refrigerated centrifuge at 2400 X g for 30 mjnutes. 
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The supernatant was acidified to pH 3.8 with 2~ acetic acid a~d allowed 
to stand overnight at 4'C, The resultant precipitate was collected by 
centrifugation at 3900 rpm (2400 X g) for 30 m:lnutes and redissolved in 
200 ml of 50 ~ phosphate buffer, pH 5.9. Following the Hamilton and 
Westheimer (1959) procedure, a heat-activation step at 55'C for 1 hour 
was performed. Protein denaturation occurs at this step and the mix-
ture was clarified by centrifugation as before. The supernatant was 
suhjected to various approaches of purification. These included preci-
pitation with ammonium sulfate at numerous concentrations, ultrafiltra-
tion, molecular exclusion chromatography, cation and anion chromato-
graphy, isoelectric focusing and isotachophoresis. Only ultrafiltration 
and isoelectric focusing techniques were useful in the characterization 
of the acetoacetate decarboxylase activity. Ultrafiltration of the heat-
activated material was performed with an Amicon Ultrafiltration Cell, 
Model 52 (Amicon Corporation, Lexington, Mass.) fitted with an XM-50 
Diaflo Ultrafiltration Membrane (Amicon Corporatlon, Lexington, V!ass.) 
which has a molecular weight cutoff of 50,000, Ultrafiltration was 
carried out with continuous stirring under a nitrogen pressure of 60 lbs 
per square inch in the cold room at 4'C, Assay of the retentate and the 
ultrafiltrate showed that the bulk of the acetoacetate decarboxylase 
activity was found in the ultrafiltrate. Although ultrafiltration mem-
branes do not yield quantitative molecula:.- ~·:eight fractionation,· it 
appears that the active material has a molecular weight range less than 
50,000, The active filtrate was ultrafiltered as before with a Diaflo 
PM-30 membrane which has a molecular weight cutoff of 30,000. Assa~r of 
the retentate and filtrate showed that the bulk of the activity was 
associated with the PM-30 ultrafiltrate although the spec:lfic activity 
of the PM-JO retentate was considerable. Table 4 lists the acetoacetate 
decarboxylase activities associated with the fractions obtained from 
ultrafiltration of the heat-activated bovine liver extract. 
The retentate and filtrate from ultrafiltration with the FH-JO 
membrane were pooled and twenty mg of proteln from the mixture was sub-
jected to isoelectric focusing in the pH range of J, 5-10 for L~8 hours at 
500 volts. Fractions of 2.5 ml each were collected from the column and 
the protein content of the effluent was monitored at 280 ~m. Figure 6 
depicts the UV absorption curve and the superimposed pH curve. The con-
tents of tubes 1 through 10 comprise the anode solution and were discard-
ed. The contents of tubes 11 through 17 were pooled and l:rophilized 
(Fraction I). The contents of tubes 18 through 45 were pooled and lyo-
philized (Fraction II). Fraction I and II were reconstituted in one ml 
of 50 mM Tris buffer, pH 7.4 and aliquots were assayed for acetoacetate 
decarboxylase activity, Fraction II was found to produce acetone at the 
-4 -1 
same rate as the reagent blank, 2 X 10 mole min • Fraction I was 
-4 -1 found to produce acetone at the rate of 4 X 10 mole min • The active 
acetoacetate decarboxylase component of bovine liver extracts has a mole-
cular weight less than JO,OOO and a pi of approximately 4. 
In 1976, Koorevaar and van Stekelenburg presented further evidence 
that mammalian acetoacetate decarboxylase activity is associated with the 
albumin fraction of human serum. As a result of this report, further 
attempts of characterizatlon of the enzymic activity from bovine liver 
were discontinued and attention was soon focused on the decarboxylase 
activity associated with human serum albumin. 
Table 4 
Acetoacetate Decarboxylase Activities of Fractions Obtained from 
Ultrafiltration of Heat-Activated Bovine Liver Extract 
Fraction 
Protein Collected After 
Acidification with Acetic Acid 
Heat Activated Material 
Retentate from 
XM-50 ( > 50,000) 
Ultrafiltrate from 
XM-50 ( < 50,000) 
Retentate from 
PM-30 ( > 30,000) 
Ultrafiltrate from 
PM-30 ( < 30,000) 
Acetoacetate 
Decarboxylase 
Activity 
(Units) 
0.86 
1.2 
0.?? 
4.1 
2.1 
4.1 
Total 
Activity 
Units x gms 
of protein 
437 
55 
259 
43 
252 
55 
Figure 6. Isoelectric resolution of the less than 50,000 molecular 
weight fraction from an ultrafiltrate of bovine liver homogenate. 
Electrophoretic resolution of a 21 mg pool of active protein 
of molecular weight less than 50,000 in a LKB 8100 electrofocusing 
column. The pH gradient extends from 3.5 to 10.0. Each tube contains 
2.5 ml. Tubes 1 throue;h 10 contain anode electrode solution; Fraction 
I (tubes 11 through 17) exhibited acetoacetate decarbox.rlase activity; 
Fraction II (tubes 18 through 45) contained no detectable acetoacetate 
decarboxylase activity. Resolved peak of Fraction I has a pi of 4. 
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Effects of Experimentally-Induced Diabetes Mellitus and of Starvation 
on the Acetoacetate Decarboxylase Activity of Rat Flasma 
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In the first paper by Van Stekelenburg and Koorevaar (1972), it is 
inferred that an enzyme is responsible for the decartoxylation of aceto-
acetate in mammalian systems. To ascertain whether the acetoacetate de-
cartoxylase activity is inducible during the metabolic stress of diabetes, 
a group of rats were made diabetic to increase their plasma concer.tra-
tion of oxybutyrates. Assay for acetoacetate decarboxylase activity dur-
ing the diabetic state will determine whether the activity is jnducible 
or constitutive. 
Adult male rats (Locke-Erickson, Maywood, Illinois) were used in 
this study and were kept in individual cages. They were acclimated jn 
the animal quarters for four days before use. Laboratory chow and water 
were provided ad libitum. At time of use, the rats had a mean body 
weight of 344 grams. Six rats were divided into two groups of three rats 
each. One group served as control animals. Streptozotocin (Upjohn Com-
pany, Kalamazoo, Michigan) was used to induce diabetes mellitus in the 
second group of rats. 
Solutions of streptozotocin are very unstable and must be injected 
within ten minutes of their preparation. The concentration of strepto-
zotocin used to induce diabetes was 65 mg/kg body w~ight. The animals 
were weighed and the appropriate amount of drug to be administered was 
weighed in small test tubes and kept at 4'C until the animals were 
prepared for the injection. 
To facilitate handling, the animals were placed under a light anes-
thesia with an intraperitoneal injection of sodium pentobarbital of a 
concentration of 32.5 mg/kg of body weight. Blood samples were collected 
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from the animals to obtain initial levels for acetoacetate decarboxylase 
activity and for plasma glucose. The animals were weighed and blood 
samples were taken between 9 a.m. and 10 a.m. on the day of the testing. 
Once the blood samples were obtained, the appropriate test tube contain-
ing the streptozotocin was diluted with 0.2 ml of 50 m~ citrate buffer, 
pH 4.5 and the solution was injected intraperltoneally. The control 
animals were handled in the same manner except that a placebo of 0.2 ml 
of the citrate buffer was used in place of the streptozotocin. 
After 24 hours, blood samples were collected from all the animals 
and the appropriate groups were reinjected wi.th streptozotocin or the 
placebo, Body weights and blood samples were obtained again after 72, 
120 and 144 hours. Glucose and acetoacetate decarboxylase levels were 
determined as previously descrlbed for all animals. 
In Table 5 are presented the changes in body weiehts, plasma f.lucose 
concentration and plasma acetoacetate decarboxylase activity durjng the 
experimental regime. Over the six day experimental period, the control 
animals maintained their weight. The streptozotocin-treated animals lost 
weight but the weight loss was not stri.king. Over the same time period, 
the glucose levels of the control animals varied little. The glucose 
levels of the streptozotocin-treated animals increased markedlY, a mean 
i.ncrease of 249% was noted after six days. The acetoacetate decarboxy-
lase activity of the plasma of both the control and the streptozotocin-
treated animals remained fairly constant, There was no evidence of a 
definite increase if1 the acetoacetate decarboxylase activity of the dia-
betic animals. Thus, the onset of the diabetic state did not induce 
acetoacetate decarboxylase activity, 
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Table 5 
Changes in Body Weight, Plasma Glucose Concentration and Plasma 
Acetoacetate Decarbo~Jlase Activity of Control and Streptozotocin-
treated Rats over a Period of Six Days and for the Streptozotocin-
treated Animals, After a Subsequent Four Day Fast. 
0 Hours 
Acetoacetate 
Glucose Decarboxylase 
Wei~ht {eJ {me;Ldl} (Units) 
Control #1 320 124 O.J? 
#2 31/J. 116 0.27 
#3 334 122 0.23 
Test #1 333 122 O.JO 
#2 349 141 0.28 
#3 414 128 0,21) 
24 Hours 
Control #1 314 136 0,3h 
#2 310 134 0.34 
#3 325 127 0.34 
Test #1 328 208 0.2) 
#2 339 311 0.21 
#J J98 J69 0,20 
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Table 5 (Continued) 
72 Hours 
Acetoacetate 
Glucose Decarboxylase 
Weight (g~ (meldl} (Uni~-
Control #1 321 114 0.25 
#2 317 124 0.2J 
#3 327 117 0.25 
Test #1 313 388 0.2J 
#2 J35 383 0.25 
#J 383 408 0.27 
120 Hours 
Control #1 322 158 O.JO 
#2 325 133 O,li-0 
#3 340 124 0.4J 
Test #1 318 428 0.31 
#2 331 
#3 395 548 0.32 
144 Hours 
Control #1 J22 134 0.58 
i/2 318 117 O.J2 
#3 334 123 0.)2 
Test #1 308 422 0.28 
#2 334 422 0.31 
#3 403 513 0.29 
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Table 5 (Continued) 
After a subsequent 4 day fast 
Acetoacetate 
Glucose Decarboxylase 
Weight (g2 (mgLdl2 ~Units2 
Test #1 258 118 0.20 
#2 280 144 0.22 
#3 333 152 0.32 
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To place more stress upon the diabetic animals, their laboratory 
chow was removed after 144 hours. The diabetic animals were starved for 
four days and blood samples were collected once again so that the aceto-
acetate decarboxylase activity could be assessed further. However, even 
starvation secondary to the diabetes did not induce an increase in the 
level of acetoacetate decarboxylase activity. 
The Effect of Acylating Agents on the Acetoacetate Decarbox}'lase Activity 
of Human Serum Albumin 
The mechanism of action for the decarboxylation of acetoacetate by 
the bacterial enzyme acetoacetate decarboxylase, occurs through a Schiff 
base intermediate which forms between the carbonyl group of acetoacetate 
and the epsilon amino terminal of a lysine residue in the active sHe. 
The formation of a Schiff base in the mechanism for decarboxvlation 
requires the presence of a free amino group. The primary source of free 
amino groups in human serum albumin would be the epsilon amino terminals 
of lysine residues. Jonas and Weber (1970) found that the epsilon amino 
groups of lysine in the bovine serum albumin molecule can be blocked after 
acylating the site with a dicarboxylic anhydride such as succinic and 
citraconic anhydride (2-methylmaleic anhydride). Maximum reaction with 
the amino groups of bovine serum albumin and succinic anh-rdrjde occur 
at a molar ratio of 15:1, anhydride to amino groups and a ?0-8o% modifi-
cation of bovine serum albumin with citraconic anhydride occurs at a 
molar ratio of 1:1, anhydr:l.de to amino groups (Jonas and Weber, 1970). 
On the basis of these consideration, it was decided to study the 
effect of acylation agents on the acetoacetate decarboxylase activity of 
human serum albumin to obtain further evidence for the formation of a 
Schiff base intermediate in the mechanism of action. 
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The free amino group content of Fraction V human serum albumin was 
determined by the method of Matthews et. al., (19(,4). A 1% solution of 
Fraction V human serum albumin (Miles Laboratories, Elkhart, Indiana), 
was found to have a free amino group content of 7.6 ~· The molar 
ratios of succinic and citraconic anhydride used in the acylations of 
albumin were based on this value. The acylations were carried out as 
described in the chapter on Materials and Methods. The succinated albu-
min solutions were lyophilized and reconstituted with 2.0 ml of 50 mM 
Tris buffer, pH 7.4. For the assay of acetoacetate decarboxylase activi-
ty, 200~1 of the reconstituted succinated album]n solution ard 0.1 ml of 
0.45 ,!:'! lithium acetoacetate solution were placed in the test reaction 
flasks. The control reaction flasks contained 200~1 of reconstituted 
unacylated human serum albumin and 0.1 ml of 0.45!! lithium acetoacetate 
solution. Table 6 shows the inhibitory effect on the acetoacetate decar-
boxylase activity of the human serum albumin of the acylating agent 
succinic anhydride in the range of molar ratios of 0.025:1 to 0.25:1, an-
hydride to free amino group. Figure 7 presents the dose dependent res-
ponse of inhibition observed for the acetoacetate decarboxylase activity 
of succinated albumin. 
Minimal acylation of human serum albumin by succinate will inhibit 
the acetoacetate decarboxylase activity. This is evident by the fact 
that the free amino group content of succinated albumin rema1ns fairly 
constant at low levels of acylation. It appears that very few s1tes on 
the albumin molecule are involved in the reaction with acetoacetate. 
The second acylating agent, citraconic anhydride, has a dist1nct 
advantage over succinic anhydride in that the ligand can be readily 
hydrolyzed from albumin (Jonas and Weber, 1970)~ Human serum albumin 
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Table 6 
Acetoacetate Decarboxylase Activity of Succinyl Human Serum Albumin 
Succinic Anhydride: Number Acetoacetate* Per cent* Free Amino 
<><.NH2 Group of Deter- Decarboxylase of Control Croup Content 
minations (Units) Activity pgjmg Protein Molar Ratio 
Control 5 1. 09 .! 0.11 0.73.! 0.29 
0.025:1 4 0.94 + 0.15 79-9.:!: 10.5 f) • 52 .! 0. 24 
0.05:1 5 0.64 + 0.13 57. 5 .! ~.9 6.68 + 0.16 
0.10:1 5 0.40.! 0.17 35.4.! 5.0 6.15 .! o. 28 
0.15:1 5 0.26.! 0,04 24.2 + 2.8 5.88.:!: 0.23 
0.20:1 5 0.21,!0.03 18.7.:!: 2.0 5. 97 .! o. 29 
0.25:1 5 0.17.:!: 0.02 14.8 + 1.7 5.81_:!:0.13 
* Mean + Standard Error of the Mean 
Figure 7. Dose dependent response of inhibition observed for 
the acetoacetate decarboxylase activity of human serum albumin 
after acylation with succinic anhydride. 
1% solutions of Fraction V human serum albumin were reacted 
with succinic anhydride. The reaction was carried out at room temper-
ature with continuous stirring and the pH maintained at 7.0 by the 
dropwise addition of 1 ~ NaOH. The reaction was deemed complete when 
no further addition of NaOH was necessary to keep the solution at pH 
7.0. Unreacted succinate was removed by dialysis agai~st water. The 
acetoacetate decarboxylase activity was determined as previously des-
cribed. The sample reaction mixture contained 2.7 ml of 50 mN Tris 
buffer, pH 7.4, 0.1 ml of 0.45 M lithium acetoacetate and 0.2-ml of the 
succinated albumin complex. For the blank reaction mixture, 0.2 ml of 
deionized water was substituted for the test sample. 
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can be acylated with citraconic anhydride and the acetoacetate decarbo-
xylase activity of the complex can be determined. After the determln-
ation of the catalytic activity, the citraconyl group can be removed and 
the albumin reassayed for acetoacetate decarboxylase activity. Subse-
quent recovery of acetoacetate decarboxylase activity upon reassay would 
demonstrate the essential need of a free epsilon amino group for catalytic 
activity of albumin. 
At a molar ratio of 1:1 citraconic anhydride to free amino content, 
the epsilon amino terminals of albumin are maximally acylated. At molar 
ratios between 0.25:1 and 1:1, the acetoacetate decarboxylase activity 
of human serum albumin was maximally inhibited. Ninhydrin assay of the 
citraconyl albumin samples demonstrated marked decreases in the free amino 
content between molar ratios of 0.25:1 and 1:1. Two molar ratios of 
citraconic anhydride to free amino group were used in the acylation, 0.10:1 
and 0.25:1. These concentrations were chosen because at a molar ratio of 
0.25:1 the acetoacetate decarboxylase activity is maximally inhibited 
while at a molar ratio of 0.10:1 the activity is inhibited by 60%. Un-
reacted citraconate was removed by passage of the acylated albumin 
through a Sephadex G-25 column. After assaying the acetoacetate decar-
boxylase activity of the citraconyl albumin samples, the ligand was re-
moved by hydrolysis. Hydrolysis was per£ormed by lowering the pH of the 
citraconyl albumin samples to 2.5 and stirring the resultant solution 
continuously at 4'C for 18 hours. The citraconate released was removed 
by passage of the samples through a Sephadex G-25 column. The acetoace-
tate decarboxylase assays for this set of experiments wer(' carrj eel out in 
the same manner as were those with succinated albumin. Table 7 lists 
the acetoacetate decarboxylase activity of human serum albumin after 
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acylation with citraconic anhydride. Table 8 presents the acetoacetate 
decarboxylase activity of human serum albumin after the removal of 
citraconyl groups from the citraconyl albumin complex. 
The acetoacetate decarboxylase act:i.vi ty of human serum albumin is 
markedly decreased by its acylation with citraconic anhydride. Inhibi-
tion of the decarboxylase activity by the acylating agent further demon-
strates the essentiality of the free amino groups for the catalytic acti-
vity associated with albumin. The inhibition of acetoacetate decarboxy-
lase activity resulting from the attachment of the citraconyl group to 
the epsilon amino groups of albumin is reversible as shown by the 
recovery of activity from the hydrolyzed citraconyl-album:in complex. 
The acetoacetate decarboxylase activities of the albumin samples 
following removal of the citraconyl group are greater than those observed 
for the citraconyl albumin complex. This qualitative difference was also 
observed for the activities of the control albumin samples subjected to 
the same conditions of hydrolysis. These phenomena may be explained in 
terms of the microheterogeneity of albumin. During the hydrolysis of the 
citraconyl albumin complex the pH of the solution is lowered to 2.5. 
Below pH 4 aibumin undergoes a transition to another molecular species 
called the expanded form (Foster et. al., 1965). In the expanded form, 
groups which were folded into the interior of the albumin molecule become 
available at the hydrophilic surface. Jonas and Heber (1970) estimate 
that after the acid expansion of bovine serum albumin, 20% of the buried 
lysire residues become uncovered. The acid expansion of albumin may 
accour.t then for the increased acetoacetate decarboxylase activity observed 
after the acid hydrolysis of the citraconyl albumin complex. However, 
of more import, was the finding that catalytic activity was recovered 
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Table 7 
Acetoacetate Decarboxylase Activity of Citraconyl Human Serum Albumin 
Citraconic 
Anhydride: 
<><. NH2 Group 
Molar Ratio 
Control 
0.10:1 
0.2.5:1 
Number Acetoacetate* 
of Deter- Decarboxylase 
minations _(Units) 
3 0.93.! 0.14 
3 0.36.! 0.08 
3 0.11 .! 0. OJ 
*Mean + Standard Error of the Mean 
Table 8 
Per Cent* 
of Control 
Activitv 
37.6 + 4.1 
11.7_!1.8 
Free Amino 
Group Content 
pg/mg Protein 
6. 6.5 .! 0, 64 
6.48.! 0.4.5 
.5.33.! o.63 
Acetoacetate Decarboxylase Activity of Human Serum Albumin After 
Removal of Citraconate from Citraconyl Albumin Complex 
Citraconic 
Anhydride: Number Acetoacetate* Per Cent* Free Amino* 
o<.. NH2 Group of Deter- Decarboxylase of Control Group Content 
minations (Units) Activity Eefmg Protein Molar Ratio 
Control 3 1.21 .! 0.1.5 t_) .11 .! o • .52 
0.10:1 3 1.11 .! 0.1.5 92.0.! 0.9 5.55.! 0.57 
0.25:1 3 0.83_!0.14 67.6.! 2.8 5.55.! 0.32 
* Mean + Standard Error of the Mean 
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from the removal of the acylating agent providing further support for a 
role of the free epsilon amino group of lysine in acetoacetate decarbo-
xylation. 
The Effect of Beta Diketones on the Acetoacetate Decarboxylase Activity 
of Human Serum Albumin. 
To obtain further evidence of acetoacetate decarboxylase activity 
associated with Fraction V human serum albumin characterization of the 
activity is necessarJ. Beta diketones are powerful competitive inhibi-
tors of the bacterial enzyme that interfere with the formation of the 
Schiff base intermediate. To demonstrate a similar relationship in the 
mechanistic scheme, the effect of two beta diketones, acetopyruvate and 
acetylacetone, on the acetoacetate decarboxylase activity of human serum 
albumin was performed. The concentration of acetopyruvate emplo::ed 
ranged from 0.10 ~to 2.0 ~and the albumin concentration in each re-
action flask was 10 mg. Table 9 shows the per cent inhibition of aceto-
acetate decarboxylase activity of the albumin at various concentrations 
of acetopyruvate. Figure 8 demonstrates the relationship between the 
concentration of acetopyruvate and the extent of inhibition by the diketone. 
The effect of acetylacetone was performed in the conce~tration 
range of 10 mM-80 mM. As with acetopyruvate, each reaction mixture con-
tained 10 mg of Fraction V human serum albumin. Table 10 shows the per 
cent inhibitio~ of acetoacetate decarboxylase activity of the albumin at 
various concentrations of acetylacetone. Figure 9 demonstrates the rela-
tionship between the concentration of acetylacetone and the extent of 
inhibition caused by the diketone. 
Both acetopyruvate and acetylacetone have marked inhibitory effects 
on the acetoacetate decarboxylase activity of Fraction V human serum 
Table 9 
Effect of Acetopyruvate Upon the Acetoacetate Decarboxylase Activity 
of Fraction V Human Serum Albumin 
Acetoacetate 
Decarboxylase 
Concentration of Number of Activity 
Acetopyruvate Determinations (Units) 
Control 5 0.98 .! 0.03 
0.10 m!1 5 0.86 .± 0.01 
0.25 m!:! 5 0.82.! 0.01 
0.,50 m!:! 5 0.72.! 0.01 
1.00 mM 5 0.66.! 0.02 
2.00 ml1 5 0.55.! 0.03 
* Mean .! Standard Error of the Mean 
Per Cent * 
Inhibition 
12.2.! 1.7 
15.9.! 1.9 
26.5.! 0.9 
32.2.! 1.7 
4J.5.! 2.6 
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Figure 8. The effect of acetopyruvate on the acetoacetate decarbo-
xylase activity of Fraction V human serum albumin. 
The acetoacetate decarboxylase activity was determined as pre-
viously described. The sample reaction mixture contained 2.h ml of 
50~~ Tris buffer, pH ?.4, 0.1 ml of a stock acetopyruvate solution 
necessary to bring its concentration in the reaction mixture to the 
predetermined level, 0.1 ml of 0.45 ~lithium acetoacetate and 10 mg 
of Fraction V human serum albumin in 0.2 ml of deionized water. For 
the blank reaction mixture 0.2 ml of deionized water was substituted 
for the test sample. 
71 
c 
0 80 
·-... 
·-
.a 
·-
-2 60 
-
.... 
c 
G) 40 
0 
.. 
G) 
D. 20 
.10.25 .50 1.0 1.5 2.0 
Acetopyruvate-mM 
Table 10 
The Effect of Acetylacetone on the Acetoacetate Decarboxylase Activity 
of Fraction V Human Serum Albumin 
Acetoacetate 
Decarboxylase 
Concentration of Number of Activity 
Acetylacetone Determinations (Units) 
Control 10 0.99 _! O.OJ 
10 mM 4 0.96..! o.oo 
20 ~ 4 0.90..! 0.01 
40 mM 4 0.50..! o.oo 
60 mM 4 0.46..! 0.05 
80 mM 4 0.22..! 0.02 
* Mean ..! Standard Error of the Mean 
Per Cent * 
Inhibition 
3.5..! O.J 
9.1..! 1.1 
49.0..! O.J 
54.0.:!: 6.2 
78.2.:!: 2.6 
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Figure 9. The effect of acetylacetone on the acetoacetate decarbo-
~rlase activity of Fraction V human serum albumin, 
The acetoacetate decarboxylase activity was determined as pre-
viously described, The sample reaction mixture contained 2.( ml 
of 50 mM Tris buffer, pH ?.4, 0.1 ml of a stock acetylacetone 
solution necessary to bring its concentration in the reaction mixture 
to the predetermined level, 0.1 ml of 0.45 M lithium acetoacetate and 
and 10 mg of Fraction V human serum albumin-in 0.2 rnl of deionized 
water. For the blank reaction mixture 0.2 ml of deionized water Has 
substituted for the test sample. 
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albumin. This observation is not unexpected if the mechanism of decar-
boxylase action by albumin occurs through a Schiff base intermediate. 
The beta diketone will react with the epsilon amino group of lysine 
rendering it inaccessible to the substrate acetoacetate. The hicr,her the 
concentration of the diketone the more effective its competition for the 
active lysine residue and therefore, the inhibition is greater. 
The Effect of Borohydride on the Acetoacetate Decarboxylase ActivHv of 
Human Serum Albumin 
Sodium borohydride is a known reductant of enzymes whose mechanism 
occurs through a Schiff base intermediate (Fischer, et. al., 1958, Grazi 
et. al., 1962, Horecker et. al., 1961, Dempsey et. al, 1962 and Fridovich 
and lrJestheimer 1962). To gain information on the mode of action for the 
acetoacetate decarboxylase activity associated with human serum albumin, 
a borohydride reduction was performed. 
Porohydride will reduce not only Schiff base intermediates but also 
the substrate acetoacetate and the product produced in the decarboxyla-
tion reaction, acetone, Thus, the assay for acetoacetate decarboxylase 
by head space analysis cannot be used in this experiment beca,Jse of the 
inacility to measure precisely the acetone release. To investi8ate the 
borohydride reduction of an albumin-acetoacetate complex the assay 
developed for trapping Schiff base intermediates (Fridovich and :festheimer 
19~2) was modified for use in this study. Incubation of 10 mg of 
14 Fractlon V human serum albumin with (J- C) acetoacetate was carried out 
in 2.9 ml of 50 zn.t! Tris buffer, pH ?.4. If the mechanism of action for 
the decarboxylation of acetoacetate occurs through a Schlff rase ir.ter-
mediate, a ketimine will be formed which is redud ble by borohydride. 
Reduction of the ketimine intermediate results in the formation of a 
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radiochemically labeled complex. The bacterial enzyme has a low K and, 
m 
therefore, when borohydride is added to the reaction mixture, there is a 
considerable amount of reduction occurring at the enzyme-substrate level. 
This is not the case for albumin because the acetoacetate decarboxylase 
activity associated with the molecule has a high Km, approximately 0.1 N 
(Koorevaar and Van Stekelenburg, 1976). The addition of borohydride to 
the albumin-reaction mixture results in a much lower level of reduction 
at the albumin complex site. To compensate for the high Km associated 
with the albumin fraction, the reduction was performed every JO minutes 
for 2 hours. Various concentrations of sodium borohydride were employed. 
The use of 1 ~and 2 ~ sodium borohydride were found to be effective 
in the trapping of a radiochemically-labeled albumin complex (Table 11). 
For each borohydride reduction of the solution containing albumin 
and (J-14c) acetoacetate, there is a significant incorporation of label 
in the albumin molecule. The radiochemically-labeled albumin complex is 
stable; its radioactivity is not lost after exhaustive dialysis. The 
trapping of the radiochemically-labeled albumin offers evidence that the 
mechanism of action utilized by Fraction V human serum albumin occurs 
through a Schiff base intermediate. 
The Effect of Acetopyruvate on the Borohydride Reduction of the Human 
14 Serum Albumin-(J- C) Acetoacetate Complex 
Acetopyruvate acts as a competitive inhibitor of the bacterial en-
zyme acetoacetate decarboxylase; the carbonyl group adjacent to the methyl 
group forms a Schiff base with the epsilon amino group of lysine in the 
active site. The resultant ketimine complex forms a non-productjve irter-
mediate which has been isolated (Tagaki et. al., 1968). The non-produc-
tive binding of acetopyruvate to the enzyme interferes with the 
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Table 11 
The Trapping of a Radiochemically-Labeled Albumin-Acetoacetate Complex 
Experiment 1 
Sample 
Control 
Experiment 2 . 
Control 
Experiment 3 
Control 
Experiment 4 
Control 
Ex.:.eeriment 5 
Control 
by Borohydride Reduction 
DPM/mg Protein 
515 
1616 
1250 
856 
1443 
1341 
1383 
2010 
450 
987 
1061 
519 
949 
1293 
Per Cent Increase 
214 
143 
57 
45 
119 
13() 
8) 
149 
r 
Experiment 6 
Sample 
Control 
1 Jn!i BH-4 
1 Jn!i BH-4 
2 Jn!i BH-4 
2 Jn!i BH-4 
Table 11 (Continued) 
DPM/mg Protein 
768 
1000 
975 
1072 
982 
Per Cent Increase 
JO 
27 
lJ.O 
28 
77 
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productive binding of acetoacetate to the active site. 
It has been shown in this study that acetopyruvate will inhibit the 
acetoacetate decarboxylase activity of Fraction V human serum alb~min. 
( ill- ) Experiments on the borohydride reduction of the albumin- J- C aceto-
acetate complex have given evidence that the mechanism of action of al-
bumin in the decarboxylation of acetoacetate occurs through a Schiff 
base intermediate. To gain further support for the mechar:isrn of action, 
the borohydride reduction of the albumin-(3-14c) acetoacetate complex 
was conducted in the presence of acetopyruvate. If a Schiff base inter-
mediate is formed between the albumin and acetoacetate, acetopyruvate 
will interfere with the binding at the active site. The competition be-
tween acetopyruvate and acetoacetate for the site will become evident by 
a decrease in the radioactivity of the borohydride-reduced albumin-aceto-
acetate complex. Preliminary studies showed that 6 ~ acetopyruvate in-
hibits the acetoacetate decarboxylase activity of human serum albumin by 
approximately 80% and this concentration of the inhibitor was used in this 
study, The borohydride reduction of the albumin-(3-14c) acetoacetate 
complex, the trapping of the radiochemically labeled albumin complex and 
the measurement of radioactivity were performed as previously described. 
Table 12 presents the extent of incorporation of the label in the albumin-
acetoacetate complex after performing the borohydride reduction in the 
prese~ce and in the absence of acetopyruvate. Acetopyruvate when incu-
14 . 
bated with (3- C) acetoacetate and Fraction V human serum albumin was 
found to inhibit the formation of a labeled acetoacetate-albumin complex. 
In tr~ee of the experiments (2,3,4), the per cent of label incorporated 
into the complex was decreased by 55 + 1. 0% (S. E. M. ) • 
Table 12 
The Effect of Acetopyruvate Upon the Borohydride 
Reduction of Albumin (3-14c) Acetoacetate 
Incorporation 
of Label 
DPM/mg Percent of 
Experiment 1 Protein Control 
(3-14c) Acetoacetate+ Human Serum Albumin 1504 
(3-14c) Acetoacetate +Human Serum Albumin 
+ 6 roN Acetopyruvate 1327 
(3-14c) Acetoacetate +Human Serum Albumin 
+ 1 m!1 BH4- 2h47 
(3- 11~c) Acetoacetate + Human Serum Albumin 
+ 6 ~ Acetopyruvate + 1 mM BH4 
Experiment 2 
8l!-1 
(3-14c) Acetoacetate +Human Serum Albumin 1630 
(3-1L"c) Acetoacetate + Human Serum Albumin 
+ 6 roM Acetopyruvate 755 
(3-14c) Acetoacetate +Human Serum Albumin 
+ 1 mM BH4- 2591 
(J-14c) Acetoacetate +Human Serum Albumin 
+ 6 ~ Acetopyruvate + 1 m~ BH4-
ExJ>eriment 3 
(3-11"c) Acetoacetate + Human Serum Albumin 
(3-14c) Acetoacetate + Human Serum Albumin 
+ 6 mM Acetopyruvate 
(3-14c) Acetoacetate +Human Serum Albumin 
771 
418 
180 
+ 1 rnM BH4 1196 
(3-14c) Acetoacetate + Human Serum Albumin 
+ 6 ~ Acetopyruvate + 1 m!1 BH4 388 
----·-· --
88 
46 
30 
43 
32 
79 
Table 12 (Continued) 
Experiment 4 
Incorporation 
of Label 
DPM/mg Percent of 
Protein Control 
(3-14c) Acetoacetate +Human Serum Albumin 430 
(3-14c) Acetoacetate +Human Serum Albumin 
+ h mM Acetopyruvate 200 
(3-14c) Acetoacetate + Human Serum Albumin 
+ 1 m!1 BH4- 1061 
(3-14c) Acetoacetate +Human Serum Albumin 
+ 6 m!1 Acetopyruvate + 1 mM BH4- 404 
47 
38 
80 
81 
For each borohydride reduction of the solution containing albumin 
and (3-14c) acetoacetate, there was, as expected, an increased incor-
poration of the label into the albumin complex in the absence of aceto-
pyruvate. In all four experiments, when the borohydride reduction was 
carried out in the presence of 6 ~ acetopyruvate significant inhibition 
of incorporation of label occurred. The incorporation was decreased by 
66 _! Z'/o (S.E.M. ). 
Acetopyruvate interferes with the borohydride reduction of the albu-
min-(3-14c) acetoacetate complex and acts in a manner similar to that ob-
served for the bacterial enzyme. It is postulated that acetopyruvate 
reacts with albumin forming a ketimine with an epsilon amino group of ly-
sine. The acetopyruvate competes with acetoacetate for the active ly-
sine residues on the albumin molecule and the competition results in 
fewer labeled ketimine intermediates available for reduction by borohy-
dride. The observed data give supportive evidence that the mechanism of 
action for the decarboxylation of acetoacetate occurs through a Schiff 
base intermediate. 
The Effect of Human Serum Albumin on the Decarboxylation of Alpha 
Ketoglutarate and Pyruvate 
The bacterial enzyme acetoacetate decarboxylase is very specific 
for acetoacetate having no action on the decarboxylation of alpha or 
other beta keto acids. To investigate the effect of Fraction V human 
serum albumin on other substrates, two alpha keto acids were chosen, 
~-ketoglutarate and pyruvate. To measure the decarboxylation rate, the 
liberation of carbon dioxide was measured radiochemically. Fifty ~Ci of 
14 . 14 (1- c) sodium pyruvate and fifty .rcJ. of (1- c) <~{-ketoglutarate (r;ew 
England Nuclear, Boston, Mass.) were brought to a concentration of 
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0.4~ with the corresponding unlabeled alpha keto acid. Each reaction 
mixture contained 10 mg of the albumin in 2.9 ml of 50 m,!::! Tris buffer, 
pH ?.ll- and 100f""l (5rCi) of the labeled keto acid solution. 'The decar-
boxylation reaction was carried o.ut at 37'C for two hours. The labeled 
carbon dioxide was trapped in the sodium hydroxide solution co~tained 
in a plastic collection bucket. The extent of decarboxylation was deter-
mined by measuring the trapped labeled carbon dioxide in the sodium hy-
droxide solution by liquid scintillation. Blank solutions containir.g 
2.9 ml of 50 m,!::! Tris buffer, pH ?.4 and 10~~1 of substrate were run to 
monitor the nonenzymatic decarboxylation. Table 13 shows the effect of 
human serum albumin (HSA) on the decarboxylation of alpha ketoGlutarate 
and pyruvate in terms of the radioactivity of the trapped labeled car-
bon dioxide. The counts obtained from the decarboxylation of ~-ketoglu­
tarate and pyruvate in the presence of Fraction V human serum albumin 
were lower than those for the corresponding blank solutions. The data 
indicate that albumin will not stimulate the decarboxylation of 
o(-ketoglutarate or pyruvate. The decarboxylation of the alpha keto 
acids in solution is actually decreased in some unknown manner by the 
albumin. 
The Effect of Bound Fatty Acids on the Acetoacetate Decarboxylase 
Activity of Human Serum Albumin 
Unlike other plasma proteins albumin has numerous functions; it is 
the principal material responsible for the oncotic pressure of the blood 
and it transports fatty acids and bilirubin. Albumin has other less 
defined functions such as the transport vehicle for tryptophan, various 
hormones and drugs; it also serves as a source of amino acids in the 
peripheral tissues. 
Table 13 
The Effect of Human Serum Albumin (HSA) on the Decarboxylation 
of Alpha Ketoglutarate and Pyruvate 
Alpha ketoglutarate 
Experiment No. Sample 
1. Reagent Blank (2) 
HSA (5) 
2. Reagent Blank (2) 
HSA (3) 
Pyruvate 
Experiment No. 
1. Reagent Blank 
HSA (4) 
2. Reagent Blank 
HSA (3) 
Radioactivity 
of the Trapped co2 DPM 
1922 
1fJt 
1088 ~ 23 (S.E.M.) 
3172 
2553 
1106 ~ 33 (S.E.M.) 
l~598 
4472 
3027 ~ 38 (S.E.M.) 
_5/-1-51 
5333 
3037 ~ 34 (S.E.M.) 
The number of determinations is shown in the parenthesis 
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Long chain fatty acids are highly insoluble at pH 7.4 and their 
presence in plasma is largely due to the binding properties of albumin. 
Ashbrook (1975) reported that 99.9% of the fatty acids in the circula-
tion are bound to albumin. One or two fatty acid residues are bound per 
molecule of albumin by the insertion of the aliphatic chains i~to the 
hydrophobic clefts of the molecule (Peters 1975). 
To investigate the effect of bound fatty acids on the acetoacetate 
decarboxylase activity of albumin, defatted Fraction V human serum albu-
min was assayed for its acetoacetate decarboxylase activity. The defat-
ted Fraction V albumin (Miles Laboratories, Elkhart, Indiar:a, Code No, 
82-323, Lot No. 13) was reported to be 98% pure as determined b:; cellu-
lose acetate electrophoresis in 0.75 ~barbital buffer, pH 8.6 and to 
contain less than 0.1 mole of fatty acid per mole of albumin. Ten mg 
samples of the defatted Fraction V human serum albumin were assayed for 
acetoacetate decarboxylase activity, as were 10 mg samples of Fraction V 
human serum albumin. Table 14 shows the percent increase in the aceto-
acetate decarboxylase activity of defatted Fraction V human serum albumin 
over that observed for Fraction V human serum albumin. This is not unex-
pected since the bound fatty acids most likely will interfere sterically 
with some of the epsilon amino groups of lysine residues. Cnce the fatty 
acids are removed from the hydrophobic clefts of albumin, more lysine 
residues are available for reaction with acetoacetate and hence, the 
acetoacetate decarboxylase activity of defatted albumin is greater. 
The Effect of Guanidine-HCl on the Acetoacetate Decarboxylase Activitv of 
Human Serum Albumin 
Guanidine-HC1 is known to cause disruptions iP the secondary 
structure of proteins. Wallevik (1973) has showl'1 by optical rotation 
Table 14 
Acetoacetate Decarboxylase Activity of Fraction V Human Serum 
Albumin and Defatted Fraction V Human Serum Albumin 
Test Material 
Fraction V Human 
Serum Albumin 
Defatted Fraction V 
Serum Albumin 
Number 
of Deter-
minations 
5 
5 
Acetoacetate* 
Decarboxylase 
Activity 
(Units) 
0.95 2: 0.0 
1. 30 .! 0.1 
* Mean + Standard Error of the Mean 
rer Cent 
Increase 
studies that minor changes occur in the secondary structure of human 
serum albumin at concentrations of less than 1 M, 
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Ten mg samples of human serum albumin were assayed in the presence 
of guanidine-H01 to study the effect that minor disruptions in the secon-
dary structure of the molecule have on the acetoacetate decarboxylase 
activity. The concentration of guanidine-HC1 used in the study ranged 
from .50 Il'l.!1-1000 Il'l.!1· Table 1.5 lists the mean percent of inhibition ob-
served in the acetoacetate decarboxylase activity resulting from second-
ary structural disruption by guanidine-HCl. A graphical representation 
of the inhibition attained in the presence of various concentrations of 
guanidine-HCl is shown in Figure 10. 
Very low concentrations of guanidine-HCl will cause a considerable 
inhibition of the acetoacetate decarboxylase activity of human serum al-
bumin. Inhibition begins to level off somewhat at a guanidine-HCl con-
centration of 400 mM. Thus, the acetoacetate decarbox:ylase activity of 
albumin is extremely sensitive to minor changes in the secondary 
structure of the molecule. 
The Effect of Various Monovalent Anions on the Acetoacetate Decarboxylase 
Activity of Human Serum Albumin 
Studies of specific effects of anions on colloidal systems in 
aqueous systems date back to Hofmeister (1888) who measured the effects 
of various salts on the solubility of egg albumin. Series of anions 
arranged in order of ability to modify some observable function and si-
milar in sequence to the series of anions found by Hofmeister are usually 
referred to as Hofmeister or Lyotropic Series (Fridovich, 1963). Aceto-
acetate decarboxylase of Q!_. acetobutylicum has been shown to be striking-
ly sensitive to inhibition by anions (Fridovich, .. 196J). The anions react 
Table 15 
The Effect of Guanidine-HCl Upon the Acetoacetate Decarboxylase 
Concentration of 
Guanidine-HCl 
Control 
50 m.M 
100 mM 
200 mM 
400 mM 
800 mM 
1000 mM 
Activity of Human Serum Albumin 
Acetoacetate 
Decarboxylase 
Number of Activity 
Determinations (Units) 
6 1.02_!0.01 
5 0.95.! 0.02 
5 0.86.! 0.02 
5 0.74.! 0.01 
5 0.57.! 0.01 
5 0.49.! 0.01 
5 0.40 + 0.01 
* Mean .! Standard Error of the Mean 
Per Cent * 
Inhibition 
7.3.! 2.2 
15.7.! 2.7 
27.2.! 1.3 
43.8 .! 1.4 
51.8.! 0.5 
60.6.! 0.5 
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Figure 10. The effect of guanidine-HC1·on the acetoacetate decarbo-
xylase activity of Fraction V human serum albumin. 
The acetoacetate decarboxylase activity was determined as pre-
viously described. The sample reaction mixture contained 2.h ml of 50 
~j Tris buffer, pH ?.4, 0.1 ml of a stock guanidine-HCl'solutjon nec-
essary to bring its concentration in the reaction mixture to the pre-
determined level, 0.1 ml of 0.45 ~lithium acetoacetate and 10 mg of 
Fraction V human serum albumin in 0.2 ml of deionized water. For the 
blank reaction mixture 0.2 ml of deionized water was substjtuted for 
the test sample. 
100 
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with the bacterial enzyme at a single sensitive site which seems to be 
cationic in nature having a pK of 5.8 or that consistent with an amino 
group (Fridovich, 1963). The ionic attraction of the anions to the sen-
sitive site on the enzyme inhibits the substrate from gaining access to 
the active site. The ionic diameter of the anion seems to play an im-
portant role in the potency of the inhibitor (Fridovich, 1963). The 
series of anions listed in order of their potency as inhibitors nearly 
parallels the Hofmeister series in reverse (Fridovich and Westheimer, 
1962; Westheimer, 1963). 
The acetoacetate decarboxylase activity of human serum albumin is 
due to a sensitive lysine residue. It is not unexpected that anions may 
also inhibit the decarboxylase activity of albumin. To further charac-
terize the acetoacetate decarboxylase activity of Fraction V human serum 
albumin, the effect of monovalent anions upon the decarboxylase activity 
was studied. Four anions from the Hofmeister series were investigated: 
bisulfite, thiocyanate, nitrate and chloride. These were chosen on the 
basis of their increasing effectiveness of inhibition of the bacterial 
enzyme of the following order: HSOj "> SCN->> NOj >> cC. For the assay, 
the test reaction mixtures contained 2.6 m1 of 50 mM Tris buffer, pH ?.4, 
0.1 ml of 0.45 ~lithium acetoacetate and 0.2 ml of a solution of Fraction 
V human serum albumin (10 mg) and 0.1 ml of a solution of the sodium salt 
of the test anion. The control reaction mixtures were prepared similarly 
except that deionized water was used instead of the test anion solution. 
Various concentrations of the anion solutions were tried in setting up 
the protocol. Table 16 lists the concentration of each anion required for 
a comparable degree of inhibition of acetoacetate decarboxylase activity 
of Fraction V human serum albumin. 
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Table 16 
The Effect of Monovalent Anions on the Acetoacetate Decarboxylase 
Activity of Albumin 
Number of 
Anion Determinations Concentration Per Cent Inhibition 
sen - 5 10 mM 4J.1%.:!: 2.8 (S.E.M.) 
Hso; 5 10 mM 41.8%.:!: o. 7 (S.E.M.) 
NO-
3 6 80 mM 40.8%.:!: 2.6 (S.E.M.) 
Cl - 6 200 mM 44.2% 2 1.0 (S.E.M.) 
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The degree of inhibition caused by the monovalent anions on the 
acetoacetate decarboxylase activity of human serum albumin parallels the 
order of effectiveness observed for the inhibition of the bacterial ace-
toacetate decarboxylase. The inhibition by monovalent anions further 
characterizes the acetoacetate decarboxylase activity of albumin and gives 
an indication that the sensitive site necessary for the decarboxylase 
activity is cationic in nature. 
The Acetoacetate Decarboxylase Activity Associated with Crystalline 
Human Serum Albumin 
Crystalline human serum albumin was assayed to obtain further evi-
dence that acetoacetate decarbo~ilase activity is not due to artifactual 
contamination. The crystalline human serum albumin was obtained from 
Calbiochem-Behring Corp., La Jolla, California. It had the following 
specifications: catalog no. 126654; lot not. 801727; A grade; specially 
prepared under non-denaturinz conditions by the method of Travis and 
Pannell (1973); composition as determined by electrophoresis, 97.6% 
albumin monomer, 2.4% albumin dimer, no alpha or beta globulins. 
Nine 10 mg samples of the crystalline albumin were assayed in the 
usual manner. The mean acetoacetate decarboxylase activity was found to 
be 0.9h ~ 0.01 (S.E.M.) units. 
In practically all studies performed with Fraction V human serum 
altum in the activity was in the range of 0, 90-1. 0 unit. Thus, it appears 
that the acetoacetate decarboxylase activity of Fraction V human serum 
albumin is not artifactural. The active component is believed to be 
integral to the albumin molecule. The assay of crystalli:re albumin and 
previous experiments with Fraction V albumin indicate that the acetoace-
tate decarboxylase activity is due solely to the presence of the albumin. 
CHAPTER IV 
DISCUSSION 
Most biochemistry textbooks cite the decarboxylation of acetoacetate 
to occur only spontaneously or nonenzymatically; a few state that the re-
action is enzymatically controlled; others do not deal with the decarbox-
ylation question at all. In 1972, Van Stekelenburg and Koorevaar pre-
sented evidence that human serum, and more specifically, the alcumin frac-
tion of human serum, contained acetoacetate decarboxylase activity. 
' . 
Their preliminary studies indicated that human serum contained active 
material whose properties were similar to those of the then known bac-
terial enzyme acetoacetate decarboxylase (EC 4.1.1.4 acetoacetate carbox-
ylase ) ;from Clostridium acetobutylicum. Among the properties of the 
postulated activator in human serum were the following: (a) the material 
is not ultrafiltrable, having a molecular weight of greater than JO,OOO, 
(b) the activator is albumin-like in nature, (c) the activity is not 
heat-stable, (d) the activity has enzyme-like substrate depende~cy, (e) 
the activity is inhibited by monoiodoacetate, urea, Hg2+ and is activated 
by lactoflavin, Also rat liver homogenates were reported to exhibit 
acetoacetate decarboxylase activity. 
To follow the work of Van Stekelenburg, bovine liver homogenates 
were used in an attempt to partially purify the acetoacetate decarboxy-
lase activity, The active component of the liver homogenates was found 
to have a molecular weight less than JO,OOO as determined by ultrafiltra-
tion (Table 4) and an isoelectric point of approximatel;y 4 (Figure f.). 
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Rat acetoacetate decarboxylase activity does not appear to be in-
ducible during diabetes mellitus (Table 5). The non-inducibility of the 
catalytic activity indicates that the acetoacetate decarboxylase activi-
ty is constitutive. 
Koorevaar and Van Stekelenburg (19?6) presented further evidence of 
mammalian acetoacetate decarboxylase activity. They demonstrated that 
the degree of polymerization of albumin had no effect on the decarboxy-
lase activity and that homogenates and subfractions of brain, liver and 
kidney had acetoacetate decarboxylase activity. Liver and kidney demon-
strated relatively high specific activities throughout all their sub-
fractions, while brain exhibited an extremely high specific activity in 
the nuclear fraction. 
If albumin is responsible for the decarboxylation of acetoacetate 
in the circulation, how does it perform this function? The mechanism 
of action for bacterial acetoacetate decarboxylase occurs through a Schiff 
base intermediate which is formed between the epsilon amino group of a 
sensitive lysine residue and the beta carbonyl group of acetoacetate. 
To investigate whether albumin has a similar mechanism of action on 
acetoacetate, albumin was acylated with dicarboxylic anhydrides. The 
acylation agents act on albumin by blocking the epsilon amino groups of 
lysine on the hydrophilic surface. Human serum albumin demonstrated 
drastic reductions in the decarboxylase activity after blockage of the 
epsilon amino groups. The epsilon amino groups of lysine in the albumin 
molecule play an integral part in mammalian acetoacetate decarboxylase 
activity. One noteworthy aspect of the inhibition by succinic anhydride 
ts that extremely small amounts of succinate will inhibit markedly the 
decarbo~rlase activity (Figure ?). At a molar ratio of 0.25:1, succinate 
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to free amino groups, the activity is inhibited by 85%. The marked in-
hibition at low molar ratios of succinic anhydride to free amino group 
indicates that relatively few "active sites" are present on the 
hydrophilic surface of albumin for reaction with acetoacetate. 
Similar results were obtained with a second acylating agent, citra-
conic anhydride (Tables 7 and 8). Low molar ratios of citraconic anhy-
dride to free amino group markedly inhibit the decarboxylase activity. 
The citraconic anhydride has a distinct advantage over succinate as an 
acylating agent in that it can be readily removed from its complex with 
albumin by hydrolysis. After hydrolysis, the resultant albumin samples 
were found to demonstrate high levels of acetoacetate decarboxylase acti-
vities. Thus, the acetoacetate decarboxylase activity can be inhibited 
by small amounts of the acylating agent and that 68% and more of the de-
carboxylase activity can be recovered after removal of the blocking agent. 
These data strengthens the findings for the blockage of the lysine 
residues with succinate. 
Behrens (1975) has determined the primary structure for huiTan serum 
albumin. Human serum albumin contains 58 lysine residues per molecule; 
however, not all of these residues have the ability to react with aceto-
acetate. The acylation of human serum albumin with dicarboxylic ar,hydrides 
has shown that the acetoacetate decarboxylase activity is drastjcally in-
hibited by minor alterations in the free amino content. Relatively few 
lysine residues appear to play a role in the decarboxylation of acetoace-
tate. 
A free epsilon amino group of lysine is necessary for the acetoace-
tate decarboxylase activity of albumin. The necessity of a free epsilon 
amino group for catalytic activity indicates that the mechanism of action 
occurs through a Schiff base intermediate. Schiff base intermediates 
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are susceptible to reduction by borohydride, In the bacterial mechanism, 
borohydride will reduce the ketimine-product intermediate (Tagak:i et. al., 
1968). The reduced ketimine-product is a stable complex which ?cts as a 
~o~-competitive inhibitor permanently tagging the enzyme with ar. inter-
mediate in the mechanism and rendering it inactive. To investigate the 
possibility of a Schiff base mechanism for the action of albumh~ 0:1 ace-
toacetate, the borohydride reduction was conducted. Freund a:-:d ;:uenke 
(19r-;2) showed that borohydride will also reduce acetone. 'i'hus, the assay 
used for the determination of acetoacetate decarboxylase by head space 
gas chromatographic analysis for acetone was not applicabJe. To measure 
the extent of the borohydride reduction, (J-14c) acetoacetate was used as 
the substrate. After reduction occurred, the albumin was tagged radio-
chemically and the formation of the reduced complex was measured by 
liquid scintillation (Table 11). 
The borohydride reducibility of the labeled albumin complex gives 
evidence that the mechanism of action for the decarboxylation of aceta-
acetate by albumin occurs through a Schiff base intermediate. 
Beta diketones are known competitive inhibitors of the bacterial en-
zyme acetoacetate decarboxylase. The diketones react with a. se~sitive 
lysine at the active site of the enzyme and prevent acetoacetate from 
gaining access to the site. If albumin decarboxylates acetoacetate 
through a Schiff base mechanism, then beta diketones would be expected to 
inhibit this decarboxylation. Acetylpyruvate (Figure 8) ar!d acetylacetone 
(Figure 9), two of the simplest diketones, were shown to inhibit the 
acetoacetate decarboxylase activity of albumin. This action of the beta 
diketones on the acetoacetate decarboxylase activity of albumin offers 
further evidence for the operation of a Schiff base mechanism. 
Acetylpyruvate, a competitive inhibitor of the bacterial enzyme, 
forms a Schiff base with the active site of the enzyme rendering it in-
accessible to acetoacetate, The Schiff base which is formed between the 
enzyme and acetylpyruvate is electron-rich in nature and borohydride will 
not reduce electron-rich Schiff bases. To gain further evidence for the 
proposed Schiff base mechanism of action for albumin on the decarboxy-
lation of acetoacetate, the effect of acetylpyruvate was studied on the 
borohydride reduction of the albumin- (J-14c) acetoacetate complex 
(Table 12). Acetylpyruvate was found to prevent the borohydride reduc-
tion of the labeled albumin complex. The inhibition of the borohydride 
reduction by acetylpyruvate strengthens the postulate that the 
decarboxylation of acetoacetate occurs through a Schiff base mechanism. 
Monovalent anions have been shown to inhibit the bacterial enzyme 
by reacting with a sensitive cationic site. The sensitive cationic site 
is the epsilon amino terminal of a lysine residue in the active site of 
"t.Le bacterial enzyme, The list of anions which cause the inhHdtion 
follows the Hofmeister series in reverse as studied by Fridovich (19/)J). 
'1'he anions possess a critical ionic volume which is necessary to inhiblt 
the bacterial enzyme. The critical ionic volume necessary to jr.hibit 
the enzyme has been explained in terms of entropy changes. In order to 
approach the cationic site, the anions must alter the hydratior: sphere of 
the cationic site. The breaking of water bonds leads to a positive or 
favorable entropy change, Once the anion has approached the cationic 
site, the hydration sphere reforms, The reformation of the hydration 
sphere leads to a negative or unfavorable entropy change. Ho·wever, the 
overall change in entropy is positive and the reaction is energetically 
favorable based upon the entropy change. 
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It was demonstrated that monovalent anions will inhibit the aceta-
acetate decarboxylase activity of human serum albumin. Four ar:ions were 
used as representative of the Hofmeister series of anions studied by 
Fridovich (1963): bisulfite, thiocyante, nitrate and chloride. The con-
centration necessary to bring about a comparable degree of inhibition was 
found to be as follows: thiocyante = bisulfite < nitrate < chloride 
(Table 1/S). The order of inhibition by monovalent anions on the acetoace-
tate decarboxylase activity of albumin is thus similar to that reported 
for the bacterial enzyme. The binding of these anions most likely occurs 
at the sensitive lysine residues of albumin and this results i~ a com-
petition between the anions and acetoacetate for the lysine sites. 
Guanidine-HCl, a known denaturant of the secondary structure of pro-
teins, was shown to inhibit the acetoacetate decarboxylase activity of 
albumin. Wallevik (1973) has shown by optical rotation that guanidine-
HCl will produce minor changes in the secondary structure of albumin at 
concentrations less than one molar. The acetoacetate decarboxylase acti-
vity of albumin has been shown to be sensitive to the minor secondary 
.... ~-
structure disruptions produced by guanidine-HCl at concentrations below 
one molar (Figure 10). The inhibition of the decarboxylase activity is 
explained by the fact that albumin contains .58 lysine resldues and minor 
changes in the secondary structure will make some of the lysires inaccess-
ible to acetoacetate. However, some of the epsilon amino groups of lysine 
still remain near the surface of the albumin after denaturation unaffec-
ted and able to react with acetoacetate. Thus, the acetoacetate decarbox-
ylase activity is not totally depleted by the denaturant. 
The albumin molecule will bind one or two long chain fatty acids, 
The sites for binding the fatty acids are probably hydrophobic clefts 
into which the aliphatic chains are inserted, Defatted Fraction V human 
serum albumin was assayed for acetoacetate decarboxylase activity a.nd 
shown to contain 36% more activity than observed for Fraction V human 
serum albumin, t0 .. 65'= 13.0 (Table 14). The long chain fatty acids of 
Fraction V human serum albumin appear to sterically interfere with the 
binding of acetoacetate and this results in a lower acetoacetate 
decarboxylase activity. 
The bacterial enzyme acetoacetate decarboxylase is very specific for 
acetoacetate having no action on alpha or other beta keto acids. Fraction 
V human serum albumin is unable to decarboxylate the alpha keto acids 
pyruvate and alpha ketoglutarate (Table 13). These results are not un-
expected for alpha keto acids will not form a Schiff base with primary 
amines (Westheimer 1963). The inability of albumin to decarboxylate 
pyruvate and alpha ketoglutarate presents evidence that the acetoacetate 
decarboxylase activity associated with human serum albumin occurs via 
the formation of a Schiff base intermediate. 
The assay of crystalline human serum albumin demonstrates the same 
acetoacetate decarboxylase activity as that observed for Fractlon V 
human serum albumin. This indicates that the activity associated with 
Fraction V albumin is not due to an artificial contaminatior. of the Cohn 
fractior.ation. The assay of crystalline albumin for the decarboxylase 
activity indicates the activity is integral to the albumin molecule. 
Koorevaar and Van Stekelenburg (1976) report a K for the acetoace-
m 
tate decarboxylase activity of albumin to be around 0.1 M. Thus, the 
affinity of albumin for acetoacetate is rather low. The high binding 
constant is compatable with the fact that during ketosis, the oxybuty-
rates become a primary fuel source for cardiac and s~Pletal muscle and, 
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therefore, decarboxylation of acetoacetate would not be desirable. Dur-
ing severe ketosis there is an increase in the proton pool and this coE-
tributes to the lowering of the blood pH. The decarboxylation of aceto-
acetate removes a proton from the pool and helps combat the fallinG blood 
pH. The low affinity of albumin for acetoacetate :insures that the oxy-
butyrates will reach the target tissue. The economy of the metabolic 
pathway dictates that albumin have a low affinity for acetoacetate. 
Based upon the assumption that the acetoacetate decarboxylase acti-
vity of human serum albumin occurs through a Schiff base mechanjsm, one 
can rationalize some of the results reported by Van Stekelenbure ar.d 
Koorevaar. For example, Van Stekelenburg and Koorevaar (1972) reported 
that human serum albumin is inhibited by iodoacetate. Iodoc_cetate re-
acts with free sulfhydryl groups; human serum albumin contair.s only one 
free half-cystine in the primary structure at position J4 (Feters, 1975). 
The closest lysine residue to this half-cystine is in position 41 and 
thus, it appears that the lysine-41 plays a major factor in the acetoace-
tate decarboxylase activity of human serum albumin. 
Van Stekelenburg and Koorevaar (1972) also report a pH optimum for 
the decarboxylation reaction involving albumin. The pH optimum can be 
explained in terms of the microheterogeneity of albumin (Foster et. al., 
1965); albumin undergoes an expansion and contraction with varying pH. 
The microheterogeneity of albumin is present in a single donor and is 
not a polymorphism within the population. The different specieG of al-
bumin resulting from microheterogeneity can be separated by their dif-
ferent electrophoretic mobilities. As the pH of albumin is lowered, a 
species known as F for the fast moving electrophoretic component evolves. 
In the pH range of 2-4·, ultracer:trifugal, visocit:y and diff1Jrdo1 
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measurements indicate that the albumin molecule expands, becoming longer 
and asymmetric without a change in molecular weight (Harrington et. al., 
1956; Foster et. al., 1965). The helical content decreases and the mole-
cule unfolds so that the interior parts become accessible (Beuson et. al., 
1964 and Wallevik, 1973). The unfolding makes more lysine residues 
available for reaction with acetoacetate. Van Stekelenburg and Koorevaar 
(1972) reported a pH optimum of 4.5. Thus, albumin is expanded and ly-
sine residues are available to react with acetoacetate. As the pH is 
raised, another species evolves, the N or normal moving electrophoretic 
species of albumin. In the N species, the secondary structure of albumin 
contracts and sensitive lysine residues become unavailable for reaction 
with acetoacetate. The microheterogeneity of human serum albumin ex-
plains the pH optimum reported by Van Stekelenburg and Koorevaar. 
Van Stekelenburg and Koorevaar (1972) described an experiment in 
which albumin was pretreated by heating at so·c for various intervals of 
time before assay of acetoacetate decarboxylase activity. The heat-
treated albumin showed a time-dependent response of inhibition. This 
thermal inactivation of albumin's acetoacetate decarboxylase activity is 
due to denaturation of the molecule. Albumin is quite resistant to ther-
mal denaturation and this accounts for the slow inactivation of the 
enzymatic activity resulting from short periods of heating. The heating 
of albumin unwinds the normal secondary structure of the molecule. 
After short periods of time, albumin will renature in a manner similar to 
its normal structure, thereby loss of the acetoacetate decarboxylase 
activity is minimized. Longer periods of heating at 80'C will demon-
strate a higher loss of activity because more intra-chain bonds are 
broken and renaturation occurs in a more random manner. After one hour 
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pretreatment of albumin at 80'C, the activity loss is 55% of its original 
activity. Of the 58 lysine residues present in albumin, some will be-
come available for reaction with acetoacetate after renaturation and thus, 
albumin still demonstrates acetoacetate decarboxylase activity after 
thermal denaturation. 
Van Stekelenburg and Koorevaar (1972) also report that mercuric ions 
will inhibit the acetoacetate decarboxylase activity of albumin. Hughes 
et, al., (1964) have shown that mercuric ions produce dimers of albumin 
by cross-linking the sulfhydryl groups. Human serum albumin contains one 
free sulfhydryl group, CySH34. Blockage of this group will ir.hibit the 
lysine in position 41 in much the same way as was observed for the inhi-
bition by iodoacetate, 
In light of the results presented in the dissertation and those 
given by Van Stekelenburg and Koorevaar, it is difficult to rationalize 
the relatively high specific acetoacetate decarboxylase activities 
associated with rat brain homogenates. Albumin will not cross the blood 
brain barrier and it is not produced endogenously in the brain. The 
brain contains numerous compounds which could form a Schiff case with 
acetoacetate in the in vitro assay, eg., dopamine, epinephrine, 
norepinephrine, glutamine, serotonin and gamma amino butyric acid. All 
of these are primary amines that would catalyze the decarboxylation of 
acetoacetate, The brain also contains decarboxylase enzymes such as dopa 
and amino acid decarboxylase. It is possible that these could decompose 
acetoacetate. The pool of free amino acids in the brain extracts could 
also be involved in the decarboxylation of a acetoacetate by virtue of 
their free amino groups. 
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Albumin is the most abundant plasma protein. Albumin does not have 
a specific function but has numerous physiological roles. It is the 
principal agent responsible for the oncotic pressure of blood, trans-
port of fatty acids and sequestration and transport of bilirubin. There 
are other less well defined functions; albumin transports various hor-
mones, acts as a source of amino acids and transports tryptophan. Tryp-
tophan is the only amino acid transported by albumin (McHenamy et. al., 
1957; McMenamy and Oncley, 1958). This fact becomes very important when 
discussing the acetoacetate decarboxylase activity of albumin. Albumin 
will not absorb lysine or any other amino acid besides tryptophan. Thus, 
the decarboxylation must be due to lysine residues which are part of the 
primary structure of albumin. 
Enzymatic activity associated with the albumin fraction is not re-
stricted to acetoacetate decarboxylase activity. Some of the other en-
zymatic activities associated with albumin include: esterase (Tove, 
1962, Casida and Augustinsson, 1959 and Poppet. al., 1966) and protease 
(Hilson and Foster, 1971), muclease (Anai et. al., 1972) and phospho-
lipase (Elsbach and Pettis, 1973). Extensive purification of the albu-
min does not affect these enzymatic activities. This indicates that the 
enzymatic activities affiliated with the albumin are not artifactual 
but due to albumin itself. 
Albumin is a very old protein in evolutionary terms, dating back be-
tween 2-3 millions years (Peters, 1975). It is interesting to note that 
albumin is the predominant circulatory protein in all species. However, 
albumin appears to have different functional roles in the various species. 
Van Stekelenburg and Koorevaar (1972) first indicated that albumin may 
function as a source of acetoacetate decarboxyla~e activity. The work 
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presented in the dissertation confirms their findings, characterizes 
the acetoacetate decarboxylase activity of albumin and presents evidence 
that the mechanism of action for the decarboxylation of acetoacetate by 
albumin occurs through a Schiff base intermediate. 
CHAPI'ER V 
SUMMARY AND CONCLUSIONS 
Experiments performed by Van Stekelenburg and Koorevaar (Clin. Chem. 
Acta J2, 191, 1972) have demonstrated the presence of acetoacetate decar-
boxylase activity associated with human serum albumin and in rat liver 
homogenates. The purpose of this work was to investigate the acetoace-
tate decarboxylase activity of Fraction V human serum albumin, to charac-
terize it further and to gain insight into the mechanism of 
decarboxylation of acetoacetate by albumin. 
Experiments utilizing bovine liver as a source of acetoacetate de-
carboxylase activity have shown the active material to have a molecular 
weight of less than 30,000 and an isoelectric point of approximately 4. 
Blockage of the epsilon amino groups of lysine in the albumin mole-
cule with succinic anhydride has demonstrated a dose-dependent response 
of inhibition on the acetoacetate decarboxylase activity. At a molar 
ratio of 0.25J1, succinate to free amino group, the acetoacetate decarbo-
xylase activity is inhibited by 8~%. The marked inhibition at low molar 
ratios of succinic anhydride to free amino group indicates that relative-
ly few "active sites" are present on the hydrophilic surface of albumin 
for reaction with acetoacetate. 
A second acylating agent, citraconic anhydride, exhibited a similar 
effect on the acetoacetate decarboxylase activity of albumin. At a molar 
ratio of 0.10:1 and 0.25:1, citracon1c anhydride to free amino group, the 
acetoacetate decarboxylase activity of albumin was inhibited by ~2% and 
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88%, respectively. Hydrolysis and subsequent removal of the citraconyl 
group resulted in recovery of the decarboxylase activity; the deacylated 
albumin samples regained 92% and 68%, respective1:y, of the jritial acti-
vities. This experiment indicates that the inhibition of acetoacetate 
decarboxylase activity resulting from the acylation is reversible. 
Schiff base intermediates are susceptible to reduction by sodium 
borohydride, It has been shown that concentrations of 1 mM and 2 ~ 
borohydride will reduce an albumin-(J-14c) acetoacetate complex causing 
between ''30% to 200% increase of label incorporated into albumin over con-
trol albumin samples not undergoing the reduction. The reduction of the 
complex by borohydride gives evidence that the mechanism of action uti-
lized by albumin for the decarboxylation of acetoacetate occurs through 
a Schiff base intermediate which forms between the carbonyl group of 
acetoacetate and the epsilon amino group of lysine, 
The acetoacetate decarboxylase activity associated with albumin is 
inhibited by the beta diketones acetopyruvate and acetylacetone, 
guanidine-HCl and various monovalent anions. At a concentration of 80 
~ acetyiacetone, the acetoacetate decarboxylase activity is inhibited 
by 78~ Acetopyruvate is a more potent inhibitor; the decarboxylase 
activity is inhibited on the order of '40% in the presence of only 2 ~ 
acetopjruvate, Acetopyruvate also will inhibit the borohydride reduc-
tion of the albumin-(;-14c) acetoacetate complex indicating that the 
diketone prevents the.formation of a Schiff base. Guanidine-HCl at 
concentrations below 1 ~ cause minor disruptions in the secondary 
structure of albumin. These minor secondary structural changes in 
albumin cause marked inhibition in the decarboxylase activity. The 
presence of 0.8 M guanidine-HCl results in a 50% loss of the acetoacetate 
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decarboxylase activity of albumin. Monovalent anions inhibit the ace-
toacetate decarboxylase activity of albumin after they are attracted to 
the sensitive cationic site of the epsilon amino terminal of lysine and, 
thereby, prevent the binding of acetoacetate to that site. The concen-
tration of anion necessary to bring about a comparable degree of inhi-
bition was found to be as follows: bisulfite = thiocyanate < nitrate< 
chloride. The efficacy of inhibition by monovalent anions on the aceto-
acetate decarboxylase activity of albumin is similar to that reported for 
the bacterial enzyme isolated from Clostridium acetobutylicum. 
Fraction V human serum albumin will not decarboxylate the alpha keto 
acids pyruvate and alpha ketoglutarate and this indicates some degree of 
specificity of the acetoacetate decarboxylase activity of albumin. The 
inability of albumin to decarboxylate the two alpha keto acids is sup-
portive evidence for the formation of a Schiff base intermediate in the 
mechanism of action since primary amines will not form a Schiff base 
with an alpha keto acid. 
The acetoacetate decarboxylase activity of defatted Fraction V hu-
man serum albumin was 36% greater than that for Fraction V human serum 
albumin. This indicates that bound fatty acids interfere with the bind-
ing of acetoacetate to some of the catalytic sites on the hydrophilic 
surface of albumin. 
These data characterize the acetoacetate decarbo~Jlase activity of 
albumin and give evidence that the mechanism of action occurs through 
a Schiff base intermediate. 
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